7
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 507-529 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • The conjugation and microencapsulation of antigens (editorial). Vopr. Virusol., 1991, 36, (4), 346–347.
  • Liposomal amphotericin B (AmBisome) in the treatment of systemic fungal infection. A symposium. Stratford-on-Avon, UK, March 1991. J Antimicrob. Chemother., 1991,28 (Suppl. B), 1–118.
  • Production of sustained-release microspheres coated with organic fine particles. ABE, E., YAMADA, N., and HIROSUE, H., Funtai Kogaku Kaishi, 1991, 28, (11), 689–693.
  • Preparation of poly(3-hydroxybutyrate) microspheres containing lastet of an anticancer drug and its application to drug delivery system. ABE, H., YAMAMOTO, Y., and Dot, Y., Kobunshi Ronbunshu, 1992, 49 (1), 61–67.
  • The ability of the cationic eosinophil major basic protein (MBP) to associate with aggregate and lyse liposomes. ABU GHAZALEH, R. I., GLEICH, G. J., and PRENDEGAST, F. G., Biophys. J., 1992, 61, (2, Part 2), A83.
  • The ability of the cationic eosinophil major basic protein (MBP) to associate with aggregate and lyse liposomes. ABU-GHAZALEH, R. I., GLEICH, G. J., and PRENDERGAST, F. G., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A83.
  • Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal am-photexicin B formulation (AmBisome). ADLER-MOORE, J. P., CHIANG, S. M., SATORIUS, A., GUERRA, D., MCANDREWS, B., MuMANus, E. J., and PROFFITT, R. T., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 63–71.
  • Attachment of antibodies to pegylated liposomes by the biotin avidin method. AGRAWAL, A. K., and ALLEN, T. M., Biophys. J., 1992, 61, (2, Part 2), A493.
  • Attachment of antibodies to pegylated liposomes by the biotin avidin method. AGRAWAL, A. K., and ALLEN, T. M., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A493.
  • Controlled-release vaccines: biodegradable polylactide-polyglycolide (PL-PG) microspheres as antigen vehicles. AGUADO, M. I., and LAMBERT, P. H., Immunobiology, 1992, 184, (2-3), 113–125.
  • Interdigitation-fusion (IF): a new method for producing lipid vesicles of high internal volume. AHL, P. L., BONI, L. T., PERKINS, W. R., SLATER, J. L., MINCHEY, S. R., TARASCHI, T. F., and JANOFF, A. S., Biophys. J., 1992, 61, (2, Part 2), A243.
  • Interdigitation-fusion (IF): a new method for producing lipid vesicles of high internal volume. AHL, P. L., BONI, L. T., PERKINS, W. R., SLATER, J. L., MINCHEY, S. R., TARASCHI, T. F., and JANOFF, A. S., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A243.
  • Preparation and release characteristics of dextromethorphan hydrobromide ion-exchange albumin microscapsule. Arnsr EUN SUN, Ku YOUNG SOON, and KIM Kit. Soo, Yakche Hakhoechi, 1991, 21, (2), 111–116.
  • Release of antisense oligodeoxynucleotide analogues from liposomes: implications for cellular transport and drug delivery. AKHTAR, S., and JuLIANo, R., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 24P.
  • Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (lipo-somes). AKIITAR, S., BASU, S., WICKSTROM, E., and JULIANO, R. L., Nucleic Acids Res., 1991, 19, (20), 5551–5559.
  • /n vitro evaluation of antibacterial of liposomal tobramycin against Pseudornonas Aeru-ginosa. ALPAR, H. 0., ROVAMO, L., DEVI, K., AMLMEIDA, A. J., COLLIER, P. J., and BROWN, M. R. W., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 122P.
  • Liposomes as vehicles for vaccines: intracellular fate of liposomal antigen in macrophages. ALVING, C. R., WASSEF, N. M., VERMA, J. N., RICHARDS, R. L., ATKINSON, C. T., and AIKAWA, M. In: Advances in Life Sciences: Progress in Membrane Biotechnology. GOMEZ-FERNANDEZ, J. C., CHAPMAN, D., and PACKER, L. (Eds). 340P. Birkhaeuser Verlag: Basel, Switzerland; 1991, pp. 195–202.
  • Method of calculating the permeability of a liposomal membrane determined by dialysis. AMBARTSUMYAN, T. G., ADAMYAN, S. YA., MARIKYAN, G. G., and PETROSYAN, L. S., Biophysics (Eng. Transl. Biofizika), 1990, 34, (1), 53–57.
  • Incorporation of water-soluble enzymes glucose oxidase and urate oxidase into phosphatidyl-choline liposomes. AMBARTSUMYAN, T. G., ADAMYAN, S. YA, PETROSYAN, L. S., and SIMONYAN, A. L., Biol. Membr., 1991, 8, (12), 1254–1259.
  • Preparation and characterization of liposomal doxorubicin for human use. AMSELEM, S., COHEN, R., DRUCKMANN, S., GABIZON, A., GOREN, D., ABRA, R. M., HUANG, A., NEW, R., and BARENHOLZ, Y., J. Liposome Res., 1991, 2, (1), 93–123.
  • Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. ANAISSIE, E., PAETZNICK, V., PROFFITT, R., ADLER-MOOFtE, J., and BODEY, G. P., Eur. J. Clin. Microbial. Infect. Dig., 1991, 10, (8), 665–668.
  • Regional delivery of microspheres to liver metastases: the effect of particle size and concentrations on intrahepatic distribution. ANDERSON, J. H., ANGERSON, W. J., WILLMOTT, N., KERR, D. J., MCARDLE, C. S., and COOKE, T. G., Br. J. Cancer, 1991, 64, (6), 1031–1034.
  • The effect of microencapsulation on the pharmacological activity of theophylline and euphylline. ANDREEVA, I. N., SARAF, A. S., and MAKAROV, V. A., Farmakol. Toksikol., 1991, 54, (5), 27–29.
  • High-stability polymerized liposomes prepared from diene-containing phosphatidylcholine. ANIKIN, A. V., CHUPIN, V. V., ANIKIN, M. V., SEREBRENNIKOVA, G. A., and EVSTIGNEEVA, R. P., Dokl. Akad. Nauk. SSSR, (Biophys.), 1991, 321, (5), 1103–1105.
  • Antigen conjugation and microencapsulation. ANON., Vopr. Virusol, 1991, 36, (4), 346-347. Metabolism of vitamin D3 administered in liposomes in rat liver. APUKHOVSKAIA, L. I., KFIRESTOVAIA, N. L., and ANTONENKO, L. V., Ukr. Biokhim. Zh., 1991, 63, (5), 89–94.
  • Effect of phospholipids purity and polyols on the temperature dependence of the permeability of liposomes. ARAKANE, K., and HAYASHI, K., J. SCCJ, 1991, 25, (3), 171–177.
  • Effect of polymer molecular weight on release rate of indomethacin from poly(D,L-lactic acid) microspheres. ARMSTRONG, D. J., ELLIOTT, P. N. C., FORD, J. L., MCCARTHY, G. P., and ROSTRON, C., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 85P.
  • Efficacy of liposome entrapped allergen in down regulation of IgE response in mice. ARORA, N., and GANGAL, S. V., Clin. Exp. Allergy, 1992, 22, (1), 35–42.
  • Stable parametric amplification using elastic microscapsules placed in silicone rubber. ASADA, T., and WATANABE, Y., Jpn. J. Appl. Phys., Part 1, 1991, 30, (Suppl. 30–1), 57–59.
  • Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages (letter). ASHTEKAR, D., DUZGUNES, N., and GANGADHARAM, P. R., J. Antimicrob. Chemother., 1991, 28, (4), 615–617.
  • Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis. Assn., K. K., FRUCHT-PERRY, J., ZIEGLER, E., SCHANZLIN, D. J., SCHNEIDERMAN, T., and WEINREB, R. N., Invest. Opthalmol. Vie. Sci., 1991, 32, (13), 3216–3220.
  • Aggregation of cardiolipin liposomes induced by monovalent ions. ATSAGORTSYAN, A. Z., VASYUKOV, A. YE, PALANKER, D. V., and NADZHARYAN, G. N., Biophysics (Engl. Transl. Biofizika), 1990, 34, (1), 48–53.
  • Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide, in solution or bound to liposomes. AVRILIONIS, K., and Boccs, J. M., J. Neuroimmunol., 1991,35, (1-3), 201–210.
  • Liposome-mediated DNA uptake by sperm cells. BACHILLER, D., SCHELLANDER, K., PELI, J., and RUTHER, U., Mol. Reprod. Dev., 1991, 30, (3), 194–200.
  • Different features of liposomes composed of naturally derived lipids within the circulation and in relation to chemical and physico-chemical characteristics. BACHMANN, D., BRANDL, M., BAUER, K. H., LUTZ, J., and AUGUSTIN, A. J., Immunolization Biotechnol., 1991, 19, (2), 350.
  • Optimization of microencapsulation of theophylline with Eudragits. Part I: Effect of different variables on microencapsulation of theophylline with Eudragits. BADAWI, A. A., SHOUKRI, R. A., and EL-ZAINY, A. A., Bull. Fac. Pharm. (Cairo Univ.), 1991, 29, (2), 69–76.
  • Microencapsulation of theophylline. Part H: Microencapsulation by simple coacervation using different techniques. BADAWI, A. A., SHOUKRI, R. A., and EL-ZAINY, A. A., Bull. Fac. Pharm. (Cairo Univ.), 1991, 29, (2), 61–68.
  • Microencapsulation of theophylline. Part I: Study of the interaction of theophylline and Eudragit-E and Eudragit-L. BADAWI, A., A., Snotixftt, R. A., and EL-ZAINY, A. A., Bull. Fac. Pharm. (Cairo Univ.), 1991, 29, (2), 55–60.
  • Dielectric relaxation in liposomes of bacteriorhodopsin. BAKARUDIN, I., Biophys. J., 1992, 61, (2, Part 2), A530.
  • Dielectric relaxation in liposomes of bacteriorhodopsin. BAKARUDIN, I., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, ( I 1), A530.
  • Uptake capacity and adsorption isotherms of doxorubicin on polymeric nanoparticles: effect of methods of preparation. BAPAT, N., and BOROUJERDI, M., Drug Dev. Ind. Pharm., 1992, 18,(1), 65–77.
  • The direct determination of protein concentration for proteins immobilized on polystyrene microspheres. BASINSKA, T., and SLomxowsKt, S., J. Biomater. Sci. Polymer. Ed., 1991,3, (2), 115–125.
  • Effects of liposome encapsulated hemoglobin on the reticuloendothelial system. BEACH, M. C., MORLEY, J., SPIRYDA, L., and WEINSTOCK, S. B., Biomater. Arti f. Cells Immobilization Biotechnol., 1991, 19, (2), 352.
  • A comparative study of free and liposome-entrapped diethylenetriaminepentaacetic acid used in the treatment of mice loaded with cadmium. BEHARI, J. R., and GREGORIADIS, G., Int. J. Pharm., 1992, 79, (2-3), 213–221.
  • Modulation of liposomal lipid peroxidation in presence of nickel by incorporation of alpha-tocopherol in the bilayer. BEHAR1, J. R., GUPTA, S., SRIVASTAVA, S., and SRIVASTAVA, R. C., J. Microencapsul., 1991, 8, (2), 215–220.
  • Effect of liposome encapsulated meso-2,3-dimercaptosuccinic acid (DMSA) on biochemical and trace metal alterations in cadmium exposed rats. BEHARI, J. R., SRIVASTAVA, S., GUPTA, S., and SRIVASTAVA, R. C., Bull. Environ. Contam. Toxicol., 1991, 47, (6), 827–833.
  • Digestion and absorption of live vs. microencapsulated Artemia nauplii by larvae of striped bass (Morone saxatilis) and inland silversides (Menidia beryllina): a histological study. BENGTSON, D. A., LEIBOVITZ, H. E., and BISBAL, G., J. World Aquacult. Soc., 1991, 22, (3), 15A.
  • Phosphatase activity and potassium transport in liposomes with sodium-potassium ATPase incorporated. BERBERIAN, G., and BEAUGE, L., Biochim. Biophys. Acta, 1992, 1103, (1), 85–93.
  • Fusion between rat brain synaptosomes and phosphatidylserine liposomes. BERNIK, D. L., RIVAS, E. A., and RODRIGUEZ-DE-LORES-ARNAIZ, G., Neurochem. Int., 1991, 19, (4), 611–618.
  • Incorporation of liposomal phytosterols into human cells in culture: a potential in vitro model for investigating pathological effects of phytosterolemia. BHADRA, S., and SUBBIAH, M. T. R., Biochem. Med. Metab. Biol., 1991, 46, (1), 119–124.
  • A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. BHAS1N, S., SWERDLOFF, R. S., STEINER, B., PETERSON, M. A., MERIDORES, T., GALMIRINI, M., PANDIAN, M. R., GOLDBERG, R., and BERMAN, N., J. Clin. Endocrinol. Metab., 1992, 74, (1), 75–83.
  • Enzyme reactions employing reverse micelles and microcapsules. BLANCH, H. W Biochem. Eng.-Stuttgart,(Proc. Int. Symp.), 2nd, 1990, Fischer, Stuttgart, Fed. Rep. Ger, publ. 1991, pp. 8–17. Ed: Reuss, M.
  • Spontaneous formation of drug-containing acrylic nanoparticles. BODMEIER, R., CHEN, H., TYLE, P., and JA,Rosz, P., J. Microencapsul., 1991, 8, (2), 161–170.
  • Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W/O/W multiple emulsion technique for water-soluble drugs. BODMEIER, R., WANG, J., and BHAGWATWAR, H., J. Microencapsul., 1992, 9, (1), 99–107.
  • Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs. BODMEIER, R., WANG, J., and BHAGWATWAR, H., J. Microencapsul., 1992, 9, (1), 89–98.
  • 'H-NMR study of the effect of Tween 20 on liposomes. BOHMOVA, M., BELLA, J., ZIEGLER, W., and POKORNY, J., Biologia (Bratislava), 1991, 46, (7), 611–617.
  • The Ca' -activated photoprotein obelin as a calcium transport inducer in proteoliposomes in the membrane of the T-system of skeletal muscles. BONDAR, V. S., VYSOTSKII, E. S., ROZHMANOVA, 0. M., and VORONINA, S. G., Biokhimiia, 1991, 56, (5), 806–811.
  • The ability of cationic amphiphilic compounds to depress the transition temperature of dipalmitoylphosphatidic acid liposomes depends on the spatial arrangement of the lipophilic moiety. BORCHARDT, K., HEBER, D., KLINGMULLER, M., MOHR, K., and MULLER, B., Biochem. Pharmacol., 1991, 42, (Suppl.), 561–S65.
  • A mathematical model of the impact and adhesion of microspheres. BRACH, R. M., and DUNN, P. F., Aerosol Sci. Technol., 1992, 16, (1), 51–64.
  • Membrane specificity of non-monotonic trends in cation-mediated injury to rapidly frozen phospholipid vesicles. BREARLEY, C. A., HODGES, N. A., and OLIFF, C. J., Chem. Phys. Lipids, 1991, 59, (2), 183–187.
  • Immunoprotection of pancreatic islet grafts within artificial microcapsules. BRUNETTI, P., BASTA, G., FALOERNI, A., CALCINARO, F., PIETROPAOLO, M., and CALAFIORE, R., Int. J. Artif. Organs, 1991, 14, (12), 789–791.
  • Production and identification of liposomes, sphingosomes, and nanoparticles. BsuNKE, R. A., and CHARLET, E., Seifen, Oele, Fette, Wachse, 1991, 117, (14), 514–517.
  • Interleukin-1 inhibits insulin secretion in isolated free and microencapsulated human islets. BUCKINGHAM, B., WANG, Z., SOON-SHIONG, P., HEINTZ, R., and VARSANYI-NAGY, M., Clin. Res., 1992, 40, (1), 34A.
  • Effect of the surface charge of liposomes on their immunoadjuvant action. BURKHANOV, S. A., and SAATOV, T. S., Dokl. Akad. Nauk. UzSSR., 1991, (1), 48–50.
  • Gentamicin encapsulation in liposomes: factors affecting the efficiency. CAJAL, Y., ASUNCION-ALSINA, M., ANTONIA-BUSQUETS, M., CABANES, A., RE1G, F., GARCIA, A., and JOSE, M., J. Liposome Res., 1991, 2, (1), 11–22.
  • Sustained release of nerve growth factor from biodegradable polymer microspheres. CAMARATA, P. J., SURYANARAYANAN, R., TURNER, D. A., PARKER, R. G., and EBNER, T. J., Neurosurgery Baltimore, 1992, 30, (3), 313–319.
  • A single blind normal volunteer bioavailability study of a new microencapsulated potassium chloride tablet compared with two reference potassium formulations. CAPLAIN, H., DAHAN, R., PAMPHILE, R., and THEBAUI,T, J. J., Eur. . J. Drug. Metab. Pharmacokinet., 1991, 16, (3), 241–244.
  • Optimization of doxorubicine incorporation and of the yield of polybutylcyanacrylate nanoparticles. CARPIGNANO, R., GAsco, M. R., and MOREL, S., Pharm. Acta Helv., 1991,66, (1), 28–32.
  • The combination of degradable starch microspheres and angiotensin II in the manipulation of drug delivery in an animal model of colorectal metastasis. CARTER, R., COOKE, T. G., HEMINGWAY, D., MCARDLE, C. S., and ANGERSON, W., Br. J. Cancer, 1992, 65, (1), 37–39.
  • Modulatory effect of two cardioglycosides on reconstituted sodium-potassium ATPase in proteoliposomes. CAVALETTO, M., GIUNTA, C., PESSIONE, E., and PERGOLA, L., Int. J. Biochem., 1991, 23, (11), 1267–1275.
  • Lateral association of class I major histocompatibility complex (MHC) glycoproteins with insulin receptors (IR) in liposomes. CHAKRABARTI, A., and EDIDIN, M., Biophys. J., 1992, 61, (2, Part 2), A147.
  • Lateral association of class I major histocompatibility complex (MHC) glycoproteins with insulin receptors (IR) in liposomes. CHAKRABARTI, A., and EDWIN, M., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A147.
  • Uptake of basic amino acids and peptides into liposomes in response to transmembrane pH gradients. CHAKRABARTI, A. C., CLARK-LEWIS, I., FIARRIGAN, P. R., and CULLIS, P. R., Biophys. J., 1992, 61, (1), 228–234.
  • Artificial viral enveloped containing recombinant human immunodeficiency virus (HIV) gp160. CHANDER, R., and SCHREIER, H., Life Sci., 1992, 50, (7), 481–489.
  • Chloroquine delivery to erythrocytes in Plasmodium berghei-infected mice using antibody-bearing liposomes as drug vehicles. CHANDRA, S., AGRAWAL, A. K., and GUPTA, C. M., J. Biosci., 1991, 16, (3), 137–144.
  • Continuous glycerolysis of olive oil by Chromobacterium viscosum lipase immobilized on liposome in reversed micelles. CHANG, PAHN SHICK, REE JOON SCHICK, and KIM JAE Jug, Biotechnol. Bioeng., 1991, 38, (10), 1159–1165.
  • Effects of different methods of administration and effects of modifications by microencapsul-ation, cross-linkage or peg-conjugation on the immunological effects of homologous and heterologous hemoglobin. CHANG, T. M. S., LISTER, C., NISHIYA, T.,, and VARMA, R., Immobilization Biotechnol., 1991, 19, (2), 367.
  • Phenylbutazone action on dimyristoyl phosphatidylcholine liposome phase transition and 8-anilino-1-naphthalene sulfonate binding. CHANTRES, J. R., and SAmiz, M. C., J. Pharm. Sci., 1992, 81, (1), 74–78.
  • Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. CHAO, F. F., BLANCHETTE-MACKIE, E. J., TERTOV, V. V., SKARLATOS, S. I., CHEN, Y. J., and KRUTH, H. S., J. Biol. Chem., 1992, 267, (7), 4992–4998.
  • In vivo protection against scorpion toxins by liposomal immunization. CHAVEZ-OLORTEGUI, C., AIT-AMARA, D., ROCHAT, H., Dixtz, C., and GRANIER, C., Vaccine, 1991, 9, (12), 907–910. Bioartificial thyroid. The in vitro culture of microencapsulated rabbit thyroid tissue. CHEN, G. X., PENG, Y., Lou, P. L., and Litt, J. P., ASAIO Trans., 1991, 37, (3), M439–M440.
  • The cytochemical changes and the adherence of neutrophil during cross-linked agarose encapsulated activated charcoal hemoperfusion. CHEN, G. X., SHU, C. D., and HE, J Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (1), 277–281.
  • The preparation of monoclonal antibody H130-homoharringtonine liposomes (immunofipo-somes) and targeting tests in vitro. CHEN, Z., Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao, 1991, 13, (5), 323–326
  • Increased binding of liposomes to cells by electric treatment. CHERNOMORDIK, L. V., PAPAFIADJOPOULOS, D., and TSONG, T. Y., Biochim. Biophys. Acta, 1991, 1070, (1), 193–197.
  • Evidence that the spectrin network and a nonosmotic force control the fusion product morphology in electrofused erythrocyte ghosts. CHERNOMORDIK, L. V., and SOWERS, A. E., Biophys. J., 1991, 60, (5), 1026–1037.
  • Laser picosecond microspectrofluorometry of haematoporphyrin in cells and liposomes. CHERNYAEVA, E. B., VARDANYAN, A. G., KOROTEEV, N. I., KAMALOV, V. F., LOBANOV, 0. V., MIRONOV, A. F., and RUMYANZEVA, V. D., J. Photochem. Photobiol. B., 1991, 10, (3), 239–248.
  • Dehydrated-rehydrated liposomes as adjuvants for streptococcus mutans oral immunization. CHILDERS, N. J., ZHANG, S., and MICHALEK, S. M., J. Dent. Res., 1992,71, (Spec. Issue Mar.), 218.
  • Mucosal and systemic responses to an oral liposome-Streptococcus mutans carbohydrate vaccine in humans. CHILDERS, N. K., MICHALEK, S. M., PRITCHARD, D. G., and MCGHEE, J. R., Reg. Immunol., 1990-91, 3, (6), 289–296.
  • Characterization of distribution behavior of 2-imidazolines into multilamellar liposomes. Cnot, Y. W., and ROGERS, J. A., J. Pharm. Sc., 1991, 80, (8), 757–760.
  • Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. CHONN, A., SEMPLE, S. C., and CULL'S, P. R., Biochim. Biophys. Acta, 1991, 1070, (1), 215–222.
  • Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. CHOPRA, R., BLAIR, S., STRANG, J., CERVI, P., PATTERSON, K. G., and GOLDSTONE, A. H., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 93–104.
  • Planar waveguide immunosensor with fluorescent liposome amplification. CHOQUETTE, S. J., LOCASCIO-BROWN, L., and DURST, R. A., Anal. Chem., 1992, 64, (1), 55–60.
  • Antiviral activity and pharmacokinetcs of liposome-encapsulated phosphonoformate in Rauscher murine leukemia virus-infected mice. CHU Cl-JUN JUNG, and SZOKA, F. C. JR., J. Liposome Res., 1991, 2, (1), 67–92.
  • Post-formation fluorescent labelling of liposomal membranes. In vivo detection, localisation and kinetics. CLAASSEN, E., J. Immunol. Methods, 1992, 147, (2), 231–240.
  • Circulation half-life and biodistribution of the freeze-dried red cell substitute liposome-encapsulated hemoglobin. CLIFF, R. 0., KLIPPER, R., PHILLIPS, W., and RUDOLF, A. S., Cryobiology, 1991, 28, (6), 589.
  • Biodegradable pseudolatexes: the chemical stability of poly(n,L-lactide) and poly(epsilon-caprolactone) nanoparticles in aqueous media. COFFIN, M. D., and MCGINITY, J. W., Pharm. Res., 1992, 9, (2), 200–205.
  • cAMP and ATP differentially affect activity and cooperativity of lipocortin I annexin I driven chromaffin granule and PS liposome aggregation. COHEN, B. E., LEE, G., and POLLARD, H. B., Biophys. J., 1992, 61, (2, Part 2), A420.
  • cAMP and ATP differentially affect activity and cooperativity of lipocortin I annexin I driven chromaffin granule and PS liposome aggregation. COHEN, B. E., LEE, G., and POLLARD, H. B., FASEB (Fed. An:. Soc. Exp. Biol. J.), 1992, 6, (1), A420.
  • The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes. COHEN, S., BERNSTEIN, H., HEWES, C., CHOW, M., and LANGER, R., PTOC. Natl. Acad. Sci. USA, 1991, 88, (23), 10440–10444.
  • Short-course treatment and response to liposomal amphotericin B in AIDS-associated cryptococcosis (letter). COKER, R., and HORNER, P. J., J. Infect. Dis., 1992, 165, (3), 593.
  • Experience with liposomal amphotericin B (AmBisome) in cryptococcal meningitis in AIDS. COKER, R. J., MURPHY, S. M., and HARRIS, J. R., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 105–109.
  • Liposomes and nanoparticles in the treatment of intracellular bacterial infections. COUVREUR, P., FATTAL, E., and ANDREMONT, A., Pharm. Res., 1991, 8, (9), 1079–1086.
  • Liposomal amphotericin B in the treatment of visceral leishmaniasis. CROFT, S. L., DAVIDSON, R. N., and THoRN-rox, E. A., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 111–118.
  • °pacification and border delineation improvement in patients with suboptimal endocardial border definition on routine echocardiography: results of a phase III trial of sonicated albumin microspheres. CROUSE, L. J., and KRAMER, P. H., Clin. Cardiol., 1991, 14, (11, Suppl. 5), V19–V22.
  • Removal of unfrozen water does not affect the stability of liposomes. CROWE, J. H., and CROWE, L. M., Biophys. J., 1992, 61, (2, Part 2), A243.
  • Removal of unfrozen water does not affect the stability of liposomes. CROWE, J. H., and CROWE, L. M., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A243.
  • pH gradients and membrane transport in liposomal systems. CuLus, P. R., BALLY, M. B., MADDEN, T. D., MAYER, L. D., and HOPE, M. J., Trends Biotechnol., 1991, 9, (8), 268–272.
  • Tumor-localizing and -photosensitizing properties of liposome-delivered germanium(IV)-octabutoxyphthalocyanine. Cuomo, V., Join, G., RIHTER, B., KENNEY, M. E., and RODGERS, M. A. J., Br. J. Cancer, 1991, 64, (1), 93–95.
  • Activation energy of the cardiac Na /Ca"- exchanger in sarcolemmal vesicles and re-constituted proteoliposomes. DALLA-SERRA, M., PEDERZOLLI, C., ANTOLINI, R., CUSINATO, F., LUCIANI, S., and MENESTRINA, G., Cardioscience, 1991, 2, (3), 193–197.
  • In vitro dissolution profile of theophylline loaded ethyl cellulose microspheres prepared by emulsification solvent evaporation. DAS, K., Drug Dev. Ind. Pharm., 1991, 17, (18), 2521–2528.
  • The alteration of permeability of small unilamellar liposomes by amphoteric alkylbetaine surfactants. DE LA MAZA, A., PARRA, J. L., GARCIA, M. T., RIBOSA, I., and SANCHEZ-LEAL, J., Colloids Surf., 1991, 61, 281–290.
  • Surfactant-promoted changes in the permeability of liposomes. DE LA MAZA, A., PARRA, J. L., GARCIA, M. T., RIBOSA, I., and SANCHEZ-LEAL, J., Comun. Jorn. Corn. Esp. Deterg., 1991,22, 305–316.
  • The temperature dependence of the refractive index of an aqueous suspension of polystyrene microspheres. DE NICOLA, S., MORMILE, P., and PIERATTINI, G., Appl. Phys. B., 1991, B53, (5–6), 350–352.
  • Binding of doxorubicin to cardiolipin as compared to other anionic phospholipids-an evaluation of electrostatic effects. DE WOLF FRITS, A., Biosci. Rep., 1991, 11, (5), 275–284. Preparation and in vitro evaluation of salbutamol sulphate microcapsules. DHARAMADHIKARI, N. B., JOSHI, S. B., and MANEKAR, N. C., J. Microencapsul., 1991, 8, (4), 479–482.
  • The effect of myotoxins isolated from Bothrops snake venoms on multilamellar liposomes: relationship to phospholipase A2, anticoagulant and myotoxic activities. DIAZ, C., GUTIERREZ, J. M., LOMONTE, B., and GENE, J. A., Biochim. Biophys. Aria, 1991, 1070, (2), 455–460.
  • Preparation of a protein-free total brain white matter lipid fraction: characterization of liposomes. DIAZ, R. S., MONREAL, J., REGUEIRO, P., and LUCAS, M., J. Neorosci. Res., 1992, 31, (1), 136–145.
  • Tuberculostatic phosphatides as liposomal substrates. Dim', I. L., CHUESHOV, V. I., STRECNIKOV, L. S., BAZAVLUK, A. D., YAKOVENKO, V. D., and SPIRIDONOV, A. V., Farmatsiya (Moscow), 1991, 40, (6), 68–69.
  • Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferon. DINNEY, C. P., UTSAGI, T., FIDLER, I. J., VON ESCHENBACH, A. C., and KILLION, J. J., Cancer Res., 1992, 52, (5), 1155–1161.
  • Repair of hepatocyte mitochondrial membranes using phosphatidylcholine liposomes. DOBRYNINA, 0. V., MIGUSHINA, V. L., SHATININA, S. Z., and KAPITANOV, A. B., Biull. Eksp. Biol. Med., 1991, 112, (8), 135–136.
  • Assessment of phosphatidylcholine (PC12) liposomes. DOHERTY, D. J., and HOUGHTON, J. A., Biochem. Soc. Trans., 1991, 19, (4), 434S.
  • Preparation properties and biological function of Liposome encapsulated hemaglobin. Domoxos, G., JoPsxt, B., and SCHMIDT, K. H., Biomater. Artif. Cells Immunobilization Biotechnol., 1991, 19, (2), 376.
  • Quantitative determination of carboxymethyl chitin in polymer-coated liposomes. DONG, C., and ROGERS, J. A., J. Microencapsul., 1991, 8, (2), 153–160.
  • Polymer-coated liposomes: stability and release of ASA from carboxymethyl chitin-coated liposomes. DoNc, C., and ROGERS, J. A., J. Controlled Release, 1991, 17, (3), 217–224.
  • Hypocrellin A induced photodamage to the fluidity of human erythrocyte membranes and membranes of some phospholipid liposomes. Du, J., QIN, J., ZHANG, X., and CHENG, L., Shih Yen Sheng Wu Hsueh Pao, 1991, 24, (4), 369–376.
  • Ibuprofen-loaded ethylcellulose microspheres mechanism involved in the growth of drug crystals in the particle surface. DUBERNET, C., BENOIT, J. P., and PUISIEUX, F., Eur. J. Pharm. Biopharm., 1991, 37, (1), 49–54.
  • Soluble polymeric drug carriers haematocompatibility. DUNCAN, R., BHAKOO, M., RILEY, M. L., and TUBOKU-METZGER, A., In Life Sciences: Progress in Membrane Biotechnology. 340P. Birkhaeuser Verlag, Basel, Switzerland; 1991, pp. 253–265.
  • ACS American Chemical Society Symposium series 469. Polymeric drugs and drug delivery systems. DUNN, R. L., and OTTENBRITE, R. M., American Chemical Society, Washington, DC USA, 1991, 313P.
  • Crosslinking with diacrylylpiperazine (PIP) reduces activation of complement by polyacryl-amide microcapsules. DUPUY, B., GIN, H., CADIC, C., BAQUEY, A., BAQUEY, C., and DUCASSOU, D., Biomater. Artif. Cells, Immobilization Biotechnol., 1991, 19, (4), 674.
  • Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes. DURING, M. J., FREESE, A., DEUTCH, A. Y., KIBAT, P. G., SABEL, B. A., LANGER, R., and ROTH, R. H., Exp. Neurol., 1992, 115, (2), 193–199.
  • Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system. DURRANI, A. M., DAVIS, N. M., TOMAS, M., and KELLAWAY, I. W., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 30P.
  • Fusion of HIV-1 and SIVmac with liposomes and modulation of HIV-1 infectivity. DUZGUNECS, N., LARSEN, C. F., KONOPKA, K., ALFORD, D. R., YOUNG, L. J., McGrtAw, T. P., DAVIS, B. R., NIR, S., and JENNINGS, M., Adv. Exp. Med. Biol., 1991, 300, 167–189; discussion 190–192.
  • CD4-mediated targeting of liposomes to HIV-infected cells. DUZGUNES, N., FLASHER, D., KONOPKA, K., and CHAMOW, S., J. Dent. Res., 1992, 71, (Spec. Issue, Mar.), 256.
  • Proteoglycan inhibition of calcification in liposomal suspensions. EANES, E. D., HAILER, A. W., MIDURA, R., and HASCALL, V., J. Dent. Res., 1992, 71, (Spec. Issue Mar.), 174.
  • Physicochemical properties of albumin microspheres determined by spectroscopic studies. EGBARIA, K., and FRIEDMAN, M., J. Pharm. Sri., 1992, 81, (2), 186–190.
  • Controlled-release frusemide microcapsules: preformulation studies. EL-S1ATTAWAY, H., KASSEM, A., and EL-RAZZAZ, M., Drug. Dev. Ind. Pharm., 1991, 17, (18), 2529–2537.
  • Phenylpropanolamine hydrochloride microcapsules: preparation and release studies. EL-SHATTAWY, H. H., KASSEM, A. A., NOUH, A. T., and EL-RAZZAZ, M. A., Drug Dev. Ind. Pharm., 1992, 18, (1), 55–64.
  • Functional reconstitution of membrane proteins in monolayer liposomes from bipolar lipids of Sulfolobus acidocaldarius. ELFERINK, M. G., DE WIT, J. G., DEMEL, R., DRIESSEN, A. J., and KONINGS, W. N., J. Biol. Chem., 1992, 267, (2), 1375–1381.
  • Coating charcoal with polyacrylate-polymethacrylate copolymer for hemoperfusion. I: Fabri-cation and evaluation. ELKHESHEN, S., ZIA, H., NEEDHAM, T. E., BADAWY, A., and Luzzi, L. A., J. Microencapsul., 1992,9, (1), 41–51.
  • Polymers for biodegradable medical devices. IX. Microencapsulation studies; effects of polymer composition and process parameters on poly-hydroxybutyrate-hydroxyvalerate microcapsule morphology. EMBLETON, J. K., and TIGHE, B. J., J Microencapsul., 1992, 9, (1), 73–88.
  • Permeability of microcapsules. FANG KUANJUN, SHAO YUN and WANG JUSHENG, Zhongguo Fangzhi Daxue Xuebao, 1991, 17, (2), 15–21.
  • Shape changes of giant liposomes induced by an asymmetric transmembrane distribution of phospholipids. FARCE, E., and DEVAUX, P. F., Biophys. . 1., 1992, 61, (2), 347–357.
  • Dissolution of compacted aspirin microcapsules. FARID, D. J., and NOKHODCHI, A., Indian J. Pharm. Sci., 1991, 53, (5), 222–223.
  • Surface ionization of dipalmitoylphosphatidylcholine as detected by the pH dependence of the phase transition temperature of liposomes. FERNANDEZ, M. S., and CALDERON, E., Ber. Bunsen Ges. Phys. Chem., 1991, 95, (12), 1669–1674.
  • Measurement of carbon clearance in mice as toxicity parameter for liposomal preparations. FICHTNER, I., KNIEST, A., and ARNDT, D., In Vivo, 1992,6, (1), 113–117.
  • Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. FIELDING, R. M., Clin. Pharmacokinet., 1991, 21, (3), 155–164.
  • Factors affecting the release rate of terbutaline from liposome formulations after intra-tracheal instillation in the guinea pig. FIELDING, R. M., and ABRA, R. M., Pharm. Res., 1992, 9, (2), 220–223.
  • New possibilities of investigation of cell macromolecular complex structures by incorporation of cells in polyacrylamide microspheres. FILATOV, M. V., VARFOLOMEEV, D. B., and KOTLOVANOVA, L. V., Tsitologiya, 1991, 33, (4), 115–120.
  • Effect of n-alkyl-N,N,N-trimethylammonium bromides on the autoperoxidation of egg yolk phosphatidylcholine in liposomes. FILIPEK, J., KOVACS, P., and BALGAVY, P., Biochem. Int., 1992, 26, (1), 79–85.
  • Influence of drug loading level on drug release and dynamic swelling of crosslinked gelatin microspheres. FORNI, F., VANDELLI, M. A., and CAMERONI, R., J. Microencapsul., 1992,9, (1), 29–39.
  • The control of protein surface concentration on proteoliposomes. FRANCIS, S. E., HUTCFIINSON, F. J., LYLE, I. G., and JONES, M. N., Colloids Surf., 1992, 62, (1-2), 177–184.
  • Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. FRIES, L, F., GORDON, D. M., RICHARDS, R. L., EGAN, J. E., HOLLINGDALE, M. R., GROSS, M., SILVERMAN, C., and ALVING, C. R., Proc. Natl. Acad. Sci. USA, 1992, 89, (1), 358–362.
  • Immunogenicity of a liposome-associated synthetic hexapeptide antigen. FRISCH, B., MULLER, S., BRIAND, J. P., VAN REGENMORTEL, M. H. V., and SCHUBER, F., Pept. 1990, Proc. Eur. Pept. Symp., 21st, 1990, ESCOM Sci. Publ., Leiden, Neth, publ, 1991, pp. 853–855. Eds: Giralt, E. and Andreu, D.
  • Detailed toxicity studies of liposomal gadolinium-DTPA. FRITZ, T., UNGER, E., WILSON-SANDERS, S., AHKONG, Q. F., and TiLcocK, C., Invest. Radiol., 1991, 26, (11), 960–968.
  • Contribution of complement system on destabilization of liposomes composed of hydrogen-ated egg phosphatidylcholine in rat fresh plasma. FUNATO, K., YODA, R., and KIWADA, H., Biochim. Biophys. Acta, 1992, 1103, (2), 198–204.
  • Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriatnycin. GABIZON, A., CHISIN, R., AMSELEM, S., DRUCKMANN, S., COHEN, R., GOREN, D., FROMER, I., PERETZ, T., SULKES, A., and BARENHOLZ, Y., Br. J. Cancer, 1991, 64, (6), 1125–1132.
  • The role of surface charge and hydrophilic groups on liposome clearance in vivo. GABIZON, A., and PAPAHADJOPOULOS, D., Biochim. Biophys. Acta, 1992, 1103, (1), 94–100.
  • Selective tumor localization and improved therapeutic index of anthracyclines incapsulated in long-circulating liposome. GABIZON, A. A., Cancer Res., 1992, 52, (4), 891–896.
  • Liposomes in dermatology and cosmetics. GABRIJELCIC, V., and SENTJURC, M., Farm. Vestn. (Ljubljana), 1991, 42, (3), 195–206.
  • Simple gas chromatographic headspace analysis of residual organic solvent in microspheres (letter). GANGRADE, N., and PRICE, J. C., J. Pharm. Sci., 1992, 81, (2), 201–202.
  • Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties. GANGRADE, N., and PRICE, J. C., J. Microencapsul., 1991, 8, (2), 185–202.
  • Mechanism of action of the peptide antibiotic nisin in liposomes and cytochrome c oxidase-containing proteoliposomes. GAO, F. H., ABEE, T., and KONINGS, W. N., Appl. Environ. Microbiol., 1991, 57, (8), 2164–2170.
  • Possibilities of using deactivation of the triplet-excited state and sensitized delayed flu-orescence to study the processes of fusion of liposomes. GASANOV, S. E., SALAKHUTDINOV, B. A., and ARIPOV, T. F., Biophysics (Engl. Transl. Biofizika), 1991, 35, (5), 916–917.
  • Doxorubicine englobed in polybutylcyanoacrylate nanocapsules: behaviour in vitro and in vivo. GASCO, M. R., MOREL, S., TROTTA, M., and VIANO, I., Pharm. Ada. Helv., 1991, 66,(2), 47–49.
  • Effect of Kampo medicines on lipid peroxidation of phosphatidylcholine liposomes. GERGEL, D., and MISIK, V., Pharmazie, 1991, 46, (6), 469–470.
  • Porins of Escherichia coli reconstituted in giant liposomes and studied by patch-clamp. GHAZI, A., BERRIER, C., COULOMBE, A., and Houssm, C., Biophys. J., 1992, 61, (2, Part 2), A513.
  • Porins of Escherichia coli reconstituted in giant liposomes and studied by patch-clamp. GHAZI, A., BERRIER, C., COULOMBE, A., and HOUSSIN, C., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A513.
  • Targeting of liposomes to hepatocytes. GHOSH, P. C., and BACHHAWAT, B. K., Targeted Diagn. Ther., 1991,4, 87–103.
  • The influence of liposomes from soybean lecithin on the efficacy of fungicides. GHYCZY, M., HAGER, J., and BOEHM, R., Meded. Fac. Landbouwwet, Rijksuniv. Gent, 1991, 56, (3a), 843–853. Insulin-carrying microspheres, in vitro studies. GIZURARSON, S., and BECHGAARD, E., Chem. Pharm.
  • Bull., 1991, 39, (7), 1892–1893.
  • Development of injectable antitumor microspheres based on polyphosphazene. GOEDEMOED, J. H., MENSE, E. H. G., DE GROUT, K., CLAESSEN, A. M. E., and SCHEPER, R. J., J. Controlled Release, 1991, 17, (3), 245–257.
  • Liposome-encapsulated hemoglobin: historical development of a blood substitute. GOINS, B., RUDOLPH, A. S., and LIGLER, F. S., Biotechnology, 1991, 19, 117–125.
  • Advances in drug delivery and targeting. GOLDSTEIN, D., and LEWIS, C., Curr. Opin. Oncol., 1991,3, (6), 1096–1104.
  • Mechanism of U and M calpain autolysis in the presence and absence of phosphatidylinositol and erythrocyte ghosts. GoLL, D. E., ZALEWSKA, T., THOMPSON, V. F., and COTTIN, P., Biophys. J., 1992, 61, (2, Part 2), A326.
  • Mechanism of MU and M calpain autolysis in the presence and absence of phosphatidyl-inositol and erythrocyte ghosts. Gott., D. E., ZALEWSKA, T., THOMPSON, V. F., and COTTIN, P., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A326.
  • Liposome leakage induced by Escherichia coli alpha haemolysin. GON1, F. M., OSTOLAZA, H., BARTOLOME, B., ORTIZ DE ZARATE, I., and DE LA CRUZ, F., Biophys. J., 1992, 61, (2, Part 2), A227.
  • Liposome leakage induced by Eseherichia coli alpha haemolysin. GoNI, F. M., OSTOLAZA, H., BARTOLOME, B., ORTIZ DE ZARATE, I., and DE LA CRUZ, F., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (I), A227.
  • Evidence that liposome incorporation of cyclosporine reduces its toxicity and potentiates its ability to prolong survival of cardiac allografts in mice. GOFtECKI, D. C., JAKOBISIAK, M., KRUSZEWISKI, A., and LASER, W., Transplantation, 1992, 52, (5), 766–769.
  • Use of liposomes for the association of foreign genetic material to spermatozoa. GORLOVA, A. V., and TORCHILIN, V. P., Biull. Eksp. Biol. Med., 1991, 112, 292–293.
  • The efficacy of immobilized liposomal preparations of ribamidil in experimental Rift Valley fever. GRABAREVA, L. P., KHAMITOV, R. A., and PSENICHNOV, V. A., Vopr. Virusol., 1991,36, (6), 512–514.
  • Liposomes in haematology. GRAY, A., and MORGAN, J., Blood Rev., 1991, 5, (4), 258–272.
  • Release of tissue plasminogen activator T-PA from temperature-sensitive liposomes in vitro. GREEN, K. L., GREGSON, R. M. C., AKHLAQ, M., and FAIRLAMB, D., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 111P.
  • Interaction of metalloporphyrin inhibitors of heme oxygenase with liposomes. GREENBAUM, N. L., Biophys. J., 1992, 61, (2, Part 2), A206.
  • Interaction of metalloporphyrin inhibitors of heme oxygenase with liposomes. GREENBAUM, N. L., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A206.
  • Overview of liposomes. GREGORIADIS, G., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 39–48. Towards a liposome-based hepatitis B virus (HBV) oligopeptide vaccine. GREGORIADIS, G., WANG, Z., and FRANCIS, M., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 31P.
  • Simultaneous injection of two liposomal antigens enhances their immunogenicity in mice. GREGORIADIS, G. and XIAO, Q., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 32P.
  • The use of macromolecular protease inhibitors to study liposome-cell interactions. GREIDZIAK, M., and LascH, J., Biomed. Biochim. Acta, 1991, 50, (8), 975–979.
  • Modification of the membrane fatty acid composition of Chlamydomonas reinhardtii algae cultured in the presence of liposomes. GRENIER, G., GUYON, D., ROCHE, 0., DUBERTRET, G., and TREMOLIERES, A., Plant Lipid Biochem. Struct. (Jill. Proc. Int. Symp. Plant Lipids, 9th, 1990, Portland Press, London, UK, pp. 367–369. Eds: Quinn, P. J. and Harwood, J. L.
  • Modification of the membrane fatty acid composition of Chlamydomonasreinhardtii cultured in the presence of liposomes. GRENIER, G., GUYON, D., ROCHE, 0., DUBERTRET, G., and TREMOLIERES, A., Plant Physiol. Biochem., 1991, 29, (5), 429–440.
  • Nanoparticles of poly-epsilon-caprolactone with digitoxin L Uptake studies. GUZMAN, M., ABERTURAS, M. R., MOLPECERES, Y. J., FESSI, H., PUISIEUX, F., and DEvissAcugr, Y. J. P., An. R. Acad. Farm., 1990, 56, (4), 443–451.
  • Fusion and fragmentation of phospholipid vesicles by apohemoglobin at low pH. HAFIN, K. H., and KIM, H., J. Biochem. (Tokyo), 1991, 110, (4), 635–640.
  • Ambisome, liposomal amphotericin B, in patients with antibiotic resistant fever due to severe neutropenia. HAHN, U., WULF, G., ACHTNICH, M., HAAS, R., and HUNSTEIN, W., Onkologie, 1991, 14, (Suppl.), 60.
  • Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. HARPER, G. R., DAVIES, M. C., DAVIS, S. S., TADROS, T. F., TAYLOR, D. C., InviNG, M. P., and WATERS, J. A., Biomaterials, 1991, 12, (7), 695–700.
  • The influence of tau-irradiation of polylactide-co-glycolide microspheres. HARIAS, S. R., COLLETT, J. H., and BOOTH, C. J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 29P.
  • Mutual recognition between polymerized liposomes IV. Polysaccharide lectin system. HASEGAWA, M., KAKU, T., KURODA, M., ISE, N., and KITANO, H., Biotechnol. Appl. Biochem., 1992, 15, (1), 40–47.
  • The preparation of microcapsule polyacrylic acid conjugates and assessment of in vitro mucoadhesion. HELLIWELL, M., MARTIN, G. P., and MARRIOTT, C., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 27P.
  • An ultrastructural study of the effects of acidic phospholipid substitutions of calcium phosphate precipitation in anionic liposomes. HEYWOOD, B. R., and EANES, E. D..; Calcif. Tissue Int., 1992, 50, (2), 149–156.
  • Effect of anomalous surface conductance on zeta-potential determination of positively charged polystyrene microspheres. HIDALGO-ALVEREZ, R., MOLEON, J. A., DE LA NIEVES, F. J., and BIJSTERBOSCH, B. H., J. Colloid Interface Sci., 1992, 149, (1), 23–26.
  • Liposome interactions with hydroxyapatite crystals: a possible mechanism in the calcification of atherosclerotic plaques. HIRSCH, D., LANDIS, W. J., AZOURY, R., and SARIG, S., Cala* f. Tissue Int., 1992, 50, (3), 261–265.
  • The microcirculation of myocutaneous island flaps in pigs studied with radioactive blood volume tracers and microspheres of different sizes. HJORTDAL, V. E., HANSEN, E. S., HENRIKSEN, T. B., KJOLSETH, D., SOBALLE, K., and DJURHUUS, J. C., Plast. Reconstr. . Surg., 1992, 89, (1), 116–124.
  • Combined liposomal interferon gamma and pentostam therapy of visceral leishmania donovani infection. HOCKERTZ, S., LUEBBING, H., and LOHMANN-MATTHES, M. L., Immuno-biology, 1991, 183, (3-4), 305.
  • Increase of permeability of synaptosomes and liposomes by the heavy chain of tetanus toxin. HOEGY, B., DAUZENROTH, M. E., HUDEL, M., WELLER, U., and HABERMANN, E., Toxi con, 1992,30, (1), 63–76.
  • The synthesis of commercially applicable microencapsulated biological material using cyanoacrylate esters. HoLL, R. J.,, Auburn University, Auburn, AL, USA, Dissertation, 1989, 414 pp.
  • Inhibition of copper-associated erythrocyte ghost membrane lipid peroxidation by hepatic cytosolic low molecular weight proteins. HOMER, B. L., PIERCE, K. R., BRIDGES, C. H., WOMACK, J. E., SOWA, B. A., and LITTELL, R. C., Toxicol. Pathol., 1991, 19, (3), 206–213.
  • Determination of megestrol acetate and estradiol valerate in injection of microencapsulated compound megestrol acetate by secondary derivative spectrophotometry. HONG, Z., Lc, B., and WANG, C., Hua Hsi I Ko Ta Hsueh Hsueh Pao, 1991, 22, (1), 87–89.
  • A pharmacokinetic evaluation of single dose gentamicin liposome injection (GLI) in normal volunteers. HORTON, M. W., SWENSEN, C. E., GOCKE, D. J., BAUSTISTA, G., WOODROW, P., SALETAN, S., and SEIBOLD, J. R., Clin. Pharmacol. Ther., 1992, 51, (2), 132.
  • Antitumor effect of adriamycin entrapped in immunoliposomes in vitro. Hu LANRONG, WEN WEI, ZHENG CHANGXUE, Wu JIAN, and DONG ZHIWIE. Shengwu Huaxue Zazhi, 1991, 7, (5), 608–612.
  • Treatment of hepatic candidosis with liposomal amphotericin B in patient with acute leukaemia (letter). HUDSON, J., SCOTT, G. L., and WARNOCK, D. W., Lancet, 1991, 338, (8781), 1534–1535.
  • The preparation and characteristics of immunoliposomes for targeting to tumour cells (A 431). HUDSON, M. J., and JONES, M. N., Biochem, Soc. Trans., 1991, 19, (4), 415S.
  • Biodegradation and antitumour effect of adriamycin-containing poly(L-lactic acid) micro-spheres. IKE, 0., SHIMIZU, Y., IKADA, Y., WATANABE, S., NATSUME, T., WADA, R., HYON, S. H., and HITOMI, S., Biomaterials, 1991, 12, (8), 757–762.
  • Adrenal P-450scc modulated activity of P-45011 beta in liposomal and mitochondrial membranes. Implication of P-450scc in zone specificity of aldosterone biosynthesis in bovine adrenal. IKUSHIRO, S., KorvuNami, S., and TAKEMORI, S., J. Biol. Chem., 1992, 267, (3), 1464–1469.
  • Physical properties and EMI (electromagnetic interference) shielding effect of polypropylene filled with microencapsulated aluminum flake. IM SUNG SOON, Kim Doo CHtml, and CHUNG CHANG NAM, Han'guk Somyu Konghakhoechi, 1990, 27, (12), 938–947.
  • Liposome-entrapped superoxide dismutase ameliorates infarct volume in focal cerebral ischaemia. ImA tzumi, S., WOOLWORTH, V., KINOUCHI, H., CHEN, S. F., FISHMAN, R. A., and CHAN, P. H. In Reulen, H. J., et al. (Eds). Acta Neurochirurgica Supplementum, 51. Brain Edema, VIII; Eighth International Symposium, Bern, Switzerland, 17–20 June 1990. 416P. Springer-Verlag: Vienna, Austria; publ. 1990, pp. 236–238.
  • Safety and efficacy of sonicated albumin microspheres in perfusion and vein graft patency assessments. IsmAIL, S., JOHNSON, S. H., UTSUNOMIYA, H., CRAIG, D., KISSLO, J. A., and SMITH, P. K., Clin. Cardiol., 1991, 14, (11, Suppl. 5), V29–V32.
  • Intrahepatic portal occlusion by microspheres: a new model of portal hypertension in the rat. JAFFE, V., ALEXANDER, B., and MATHIE, R. T., Gut, 1991, 32, (10), A1210–A1211.
  • Reduction by norepinephrine of the side effects induced by combined hepatic arterial administration of degradable starch microspheres and adriamycin in rats with a liver adenocarcinotna. JAKOBSSON, B., TEDER, H., Roos, G., and STENRAM, U., Sel. Cancer Ther., 1991, 7, (3), 93–101.
  • Calmodulin activation of the calcium pump revealed by fluorescent chelator dyes in human red blood cell ghosts. JAMES-KRACKE, M. R., J. Gen. Physiol., 1992, 99, (1), 41–62.
  • Polystyrene nanosphere and microsphere uptake and translocation via the gut mucosa after a single oral dose. JAN1, P. U., FLORENCE, A. T., and MCCARTHY, D., J. Pharm. Pharmacol., 43, 1991, (Suppl.), Abstract 28P.
  • Chromatographic fractionation of nucleic acids using microcapsules made from plant cells. JASCHKE, A., CECH, D., and EHWALD, R., J. Chromatogr., 1991, 585, (1), 57–65.
  • Antimicrobial peptides of the magainin family: membrane depolarization studies on E. coiland cytochrome oxidase liposomes. JURETIC, D., Stud. Biophys., 1990, 138, (1–2), 79–86. Studies on the exchange of gramicidin in liposomes. JYOTHI, G., MITRA, C. K., and
  • KRISHNAMOORTHY, G., Bioelectrochem. Bioenerg., 1991, 26, (3), 395–402.
  • Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver. KABALKA, G. W., DAVIS, M. A., HOLMBERG, E., MARUYAMA, K., and HUANG, L., Magn. Reson. Imaging, 1991,9, (3), 373–377.
  • Influence of injection volume on the release kinetics of liposomal chloroquine administered subcutaneously or intramuscularly to mice. KADIR, F., ELING, W. MC., CROMMELIN, D. J. A., and ZUIDEMA, J., J. Controlled Release, 1991, 17, (3), 277–284.
  • ,Cold tolerance and other physiological characteristics of freshwater amoeba after treatment with liposomes from lecithin. KALININA, L., Cryobiology, 1991, 28, (6), 596–597.
  • Liposomes as a model for the study of the mechanism of fish toxicity of sodium dodecyl sulfate in sea water. KALMANZON, E., ZLOTKIN, E., COHEN, R., and BARENHOLZ, Y., Biochim. Biophys. Acta, 1992, 1103, (1), 148–156.
  • Alterations of biophysical properties of liposomes predict aminoglycoside toxicity: inhibitory effect of polyaspartic acid. KALOYANIDES, G. J., and RAMSAMMY, L., Nephrotoxicity, Dekker, New York, NY, 1991, pp. 117–125. Ed: Bach, P. H.
  • Preparation and characterization of immunoliposomes for targeting of antiviral agents. KALVAKOLANU, D. V. R., and ABRAHAM, A., Bio Techniques, 1991, 11, (2), 218–220. 222, 224–225.
  • Dielectric analysis of sheep erythrocyte ghost. Examination of applicability of dielectric mixture equations. KANEKO, H., ASAMI, K., and HANAI, T., Colloid Polym. Sci., 1991, 269, (10), 1039–1044.
  • Functional reconstitution of plasma membrane hydrogen ion ATPase from mung bean ( Vigna radiata L.) hypocotyls in liposomes prepared with various molecular species of phospholipids. KASAMO, K., and YAMANISHI, H., Plant Cell Physiol., 1991, 32, (8), 1219–1225.
  • Physicochemical characteristics of hepatic stimulatory factor prepared from cell free supernatant of hepatocyte cultures. KASHANI, S. A., and CHANG, T. M., Biomater. Artif . Cells Immobilization Biotechnol., 1991, 19, (3), 579–598.
  • Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model. KASHANI, S. A., and CHANG, T. M., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (3), 565–577.
  • The preparation and characterisation of proteoliposomes for targeting to oral bacteria. KASZUBA, M., FRANKLIN, M., HILL, K. J., and JONES, M. N., Biochem. Soc. Trans., 1991, 19, (4), 416S.
  • Characterization of apolipophorin III incorporated in liposomes. KATAGIRI, C., and HIRAOKA, T., Zoo/. Sci. Tokyo., 1991, 8, (6), 1146.
  • Biomedical application of microspheres. KAWAGUCHI, H., Zairyo Gtjutsu, 1991, 9, (10), 323–327. Hydrogel microspheres. III. Temperature-dependent adsorption of proteins on poly(N isopropylacrylamide) hydrogel microspheres. KAWAGUCHI, H., FujimoTo, K., and
  • MIZUHARA, Y., Colloid. Polym. Sci., 1992, 270, (1), 53–57.
  • Hollow microspheres for use as a floating controlled drug delivery system in the stomach. KAWASHIMA, Y., NIWA, T., TAKEUCHI, H., HINO, T., and Prox, Y., J. Pharm, Sci., 1992, 81, (2), 135–140.
  • Adhesion of nanoparticles within spray-dried agglomerates. KENDALL, K., and WEIHS, T. P., J. Phys. D: Appl. Physics., 1992, 25, (1A), A3–A8.
  • Interaction of d6 dimethyl sulfoxide with egg phosphatidylcholine liposome using proton nuclear magnetic resonance spectroscopy (PNMR). KHAN, Z. U., AHMAD, B., and JAMSHAID, M., J. Pure Appl. Sci., 1990, 9, (2), 7–12.
  • The influence of some non-ionic polymers on liposome biodistribution in the rabbit. KHATTAB, M. A., FARE, S. J., LOVE, W. G., and KELLAWAY, I. W., J. Pharm. Pharmacol., 43, 1991, (Suppl.), Abstract 96P.
  • Preparation and characteristics of unsaturated PE (phosphatidylethanolamine) immunolipo-some incorporated with ganglioside GM. KIM CHANG Soo, LEE EUN OK, and Kum JONG DUK, Yakche Hakhoechi, 1991, 21, (3), 161–170.
  • Vesicle to micelle transitions of egg phosphatidylcholine liposomes induced by nonionic surfactants, poly(oxyethylene) cetyl ethers. Kum, J. G., and Kim, J. D., J. Biochem. (Tokyo), 1991, 110, (3), 436–442.
  • Efficiency of oral administration of liposomal tocopherol preparation to animals. KIRILENKO, V. M., STEFANOV, 0. V., KUZMENKO, I. V., and Ma:mut-tux, D. 0., Dokl. Akad. Nauk. Ukr. SSR, 1991, (10), 151–153.
  • Mutual recognition between polymerized liposomes. III. Association processes between avidin and biotin on polymerized liposome surfaces. KITANO, H., KATO, N., and IsE, N., Biotechnol. Appl. Biochem., 1991, 14, (2), 192–201.
  • Microspheres prepared from temperature-sensitive graft polymers. KITANO, H., YAN, C., and NAKAMURA, K., Makromol. Chem., 1991, 192, (12), 2915–2923.
  • Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid). KLEINERMAN, E. S., RAYMOND, A. K., BUCANA, C. D., JAFFE, N., HARRIS, M. B., KRAKOFF, I. H., BENJAMIN, R., and FIDLER, I. J., Cancer Immunol, Immunother., 1992, 34, (4), 211–220.
  • Liposome-embedded-heme as a totally artificial oxygen carrier. KOBAYASHI, K., WATANABE, M., ISHIHARA, T., NISHIDE, H., and TSUCHIDA, E., ASAIO Trans., 1991, 37, (3), M443–M444.
  • Liposome-embedded heme: totally synthetic oxygen carrier and its oxygen carrying capacity. KOBAYASHI, K., WATANABE, M., ISHIHARA, T., NISHIDE, H., and TSUCHIDA, E., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (2), 412.
  • Anthrax toxin protective antigen: low-pH-induced hydrophobicity and channel formation in liposomes. KOEHLER, T. M., and COLLIER, R. J., Mol. Microbial., 1991, 5, (6), 1501–1506.
  • Permeability of liposomal membranes to water: results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions. KOENIG, S. H., AHKONG, Q. F., BROWN, R. D., LAFLEUR, M., SPILLER, M., UNGER, E., and TuxocK, C., Magn. Reson. Med., 1992, 23, (2), 275–286.
  • Catalytic and photochemical properties of haemoproteinoid microspheres. KOLESNIKOV, M. P., and MAKSUDOVA, N. 1., Biophysics (Engl. Transl. Biofizika), 1991, 35, (5), 768–772.
  • Characteristics of microcapsule membranes as viewed from a standpoint of membrane science. KONDO, T., Maku, 1991, 16, (3), 169–177.
  • HIV-1 infection of a non-CD4-expressing variant of HUT-78 cells: lack of inhibition by Leu3A antibodies and enhancement by cationic DOTMA liposomes. KONOPKA, K., DAVIS, B. R., and DUZGUNECS, N., Adv. Exp. Med. Biol., 1991, 300, 97–110.
  • Pyrene excimer formation dynamics in a single microcapsule by space- and time-resolved fluorescence spectroscopy. KOSHIOKA, M., MISAWA, H., SASAKI, K., RITAMURA, N., and MASUHARA, H., J. Phys. Chem., 1992, 96, (7), 2909–2914.
  • Free versus microencapsulated pancreatic islet xenografts producing amelioration of strepto-zotocin toxicity. KRESTOW, M., Lum, Z. P., TAI, I. T., and SUN, A. M., Biomater. Artif. Cells Immunobilization Biotechnol., 1922, 20, (1), 43–51.
  • Application of microencapsulation technology to improve the stability of citral in rodent diets. KUHN, G. 0., MCCAMPBELL, P., SINGMASTER, G., ARNESON, D. W., and JAmEsolv, C. W., Fundam. Appl. Toxicol., 1991, 17, (3), 635–640.
  • Liposomes in drug delivery system for cancer treatment. KUMAI, K., TADAKUMA, T., and YASUDA, T., Drug Delivery Syst., 1991, 6, (6), 415–421.
  • ESR and PMR studies of the interaction of the polynucleotides with phosphatidylcholine liposomes and bivalent cations. KUVICHKIN, V. V., VOLKOVA, L. A., NARYSHKINA, YE. P., and ISANGALIN, F. SH., Biophysics (Eng. Transl. Biofizika), 1990, 34, (3), 436–441.
  • Laser emission from dye-doped polystyrene microsphere. KUWATA-GONOKAMI, M., TAKEDA, K., YASUDA, H., and EMA, K., Jpn. J. Appl. Phys., Part 2, 1992, 31, (2A), L99–L101.
  • Release of macromolecules from albumin-heparin microspheres. KWON, G. S., BAE, Y. H., CREMERS, H., FEIJEN, J., and KIM, S. W., Int. J. Pharm., 1992, 79, (2-3), 191–198.
  • Phospholipid vesicles as a drug delivery system. Part. Interaction of cytidine-5'-diphosphate choline with charged and zwitterionic phospholipids. LA ROSA, C., GRASSO, D., FRESTA, M., VENTURA, C., and Pncusi, G., Thermochim. Acta, 1992, 195, 139–148.
  • Adenosine triphosphate (ATP) liposomes: description of an original method of preparation and physicochemical characterization of the vesicles obtained. LAHAM, A., DELATTRE, J., COUVREUR, P., ROSSIGNOL, P., CLAPERON, N., and PUISIEUX, F., STP Pharma, 1990,6, (10), 716–722.
  • Biodegradable polymer: Poly(lactic acid): Part II: Evaluation as a matrix material for controlled release and as a microencapsulating agent. LALLA, J. K., and CHUGH, N.N., Indian Drugs, 1990, 27, (10), 523–529.
  • Photoinduced destabilization of liposomes. LAMPARSKI, H., LIMAN, U., BARRY, J. A., FRANKEL, D. A., RAMASWAMI, V., BROWN, M. F., and O'BRIEN, D. F., Biochemistry, 1992, 31, (3), 685–694.
  • Development of echogenic liposomes for tissue-specific ultrasonic image enhancement. LANZA, G. M., ALKAN, M. H., VONESH, M. J., KLEGERMAN, M. E., FRAZIN, L. J., MEHLMAN, D. J TALANO, J. V., and MCPHERSON, D. D., J. Am. Coll. Cardiol., 1992, 19, (3, suppl. A), 114A.
  • How deep do intact liposomes penetrate into human skin? LASCH, J., LAUB, R., and WoHLRAB, W., J. Controlled Release, 1992, 18, (1), 55–58.
  • Magnetic resonance methods in the studies of liposomes. LASIC, D. D., Bull. Magn. Reson., 1991, 13, (1-2), 3–13.
  • Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. LASIC, D. D., MARTIN, F. J., GABIZON, A., HuANG, S. K., and PAPAHADJOPOULOS, D., Biochem. Biophys. Acta, 1991, 1070, (1), 187–192.
  • Effect of stabilization temperature on the degradation of adriamycin in albumin micro-spheres. LAW, S. L., CHIANG, C. H., Los, F. M., and TEH, G. W., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (3), 613–629.
  • Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococ-cosis and pulmonary aspergillosis. LE CONTE, P., JoLy, V., SAINT JULIEN, L., GILLARDIN, J. M., CARBON, C., and YENI, P., Am. Rev. Respir. Dis., 1992, 145, (2, Part 1), 424–429.
  • Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. I. Antioxidant enzyme activities and lipid peroxidation. LEDWOZYW, A., Acta Vet. Hung., 1991, 39, (3-4), 215–224.
  • Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. H. Phospholipids of the lung surfactant. LEDWOZYW, A., Acta Physiol. Hung., 1991, 78, (2), 157–162.
  • Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. LEE, K. D., HONG, K., and PAPAHADJOPOULOS, D., Biochim. Biophys. Acta, 1992, 1103, (2), 185–197.
  • Effect of amphipathic peptides with different alpha-helical contents on liposome-fusion. LEE, S., Aoict, R., OISHI, 0., AOYAGI, H., and YAMASAKI, N., Biochim. Biophys. Acta, 1992, 1103, 157–162.
  • Liposomes and cell targeting of nucleic acids. LESERMAN, L., Colloq. INSERM, 1991, 219 (Hum. Gene Transfer), 75–82.
  • The effect of phosphatidylcholine liposomes on lipid peroxidation in the liver and phospholipid metabolism in hepatocyte plasma membrane in hemorrhagic shock. LESKOVA, G. F., and UDOVICHENKO, V. I., Patol. Fiziol. Eksp. Ter., 1991, (6), 46–47.
  • Maintenance of long-term secretory function by microencapsulated islets of Langerhans. LEVESQUE, L., BRUBAKER, P. L., and SUN, A. M., Endocrinology, 1992, 130, (2), 644–650.
  • Preparation of chitosan microspheres containing fluorouracil using the "dry-in-oil" method and its release characteristics. Li, Y. P., MACHIDA, Y., SANNAN, T., and NAGAI, T., STP Pharma Sci., 1991, 1, (6), 363–368.
  • The sucrose carrier of the plant plasmalemma. III. Partial purification and reconstitution of active sucrose transport in liposomes. Li, Z. S., GALLET, 0., GAILLARD, C., LEMOINE, R., and DELROT, S., Biochim. Biophys. Acta, 1992, 1103, (2), 259–267.
  • Permeability study of phospholipid liposomes prepared by reverse phase evaporation method. Lim, K., and CHOI, M. U., Korean Biochem. J., 1991, 24, (6), 609–616.
  • Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: (II). Effect of temperature and pH on the stability and release behaviour of microspheres. LIN, S. Y., TZAN, Y. L., WENG, C. N., and LEE, C. J., J. Microencapsul., 1991, 8, (4), 537–545.
  • Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidyleth-anolamine liposomes. LITZINGER, D. C., and HUANG, L., Biochim. Biophys. Acta, 1992, 1104, (1), 179–187.
  • Potentiation of the humoral response of intravenous antigen by splenotropic liposomes. Liu, D. X., WADA, A., and Huarsic, L., Immunol. Lett., 1992, 31, (2), 177–181.
  • Size homogeneity of a liposome preparation is crucial for liposome biodistribution in vivo. Liu, D., and HUANG, L., J. Liposome Res., 1991, 2, (1), 57–66.
  • Role of liposome size, and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. LIU, D., MORI, A., and HUANG, L., Biochim. Biophys. Acta, 1992, 1104, (1), 95–101.
  • Trimethylammoniocarboxylates as liposome, and erythrocyte cryoprotectants. LLOYD, A. W., RUTT, K. J., and OLLIFF, C. J., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 97P.
  • Liposome-mediated delivery stimulates a class I-restricted cytotoxic T cell response to soluble antigen. LOPES, L. M., and CHAIN, B. M., Eur. J. Immunol., 1992, 22, (1), 287–290.
  • Human growth hormone production after in vivo arterial gene transfer in rabbit artery: foreign protein synthesis following liposome mediated transfection. LOSORDO, D. W., LECLERC, G., GAL, D., WEIR, L., and ISNER, J. M., J. Am. Coll. Cardiol., 1992, 19, (3. Suppl. A), 102A.
  • Partitioning of a homologous series of alkyl p-aminobenzoates in dipalmitoylphosphatidyl-choline liposomes: effect of liposome type. MA, L., RAMACHANDRAN, C., and WEINER, N. D., Int. J. Pharm., 1991, 77, (2-3), 127–140.
  • Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates mono-cyte production of tumor necrosis factor and interleukin-1 in vitro. MAEDA, M., KNOWLES, R. D., and KLEINERMAN, E. S., Cancer Commun., 1991, 3, (10-11), 313–321.
  • Sequence of critical events involved in fusion of phospholipid vesicles induced by clathrin. MAEZAWA, S., and YOSIIIMURA, T., Biochim. Biophys. Acta, 1991, 1070, (2), 429–436.
  • Self-regulated delivery of insulin from microcapsules. MAKIN°, K., MACK, E. J., OKANO, T., and KIM, S. W., Biotnater. Artif. Cells Immobilization Biotechnol., 1991, 19, (1), 219–228.
  • Temperature- and ionic strength-induced conformational changes in the lipid head group region of liposomes as suggested by zeta potential data. MAKIN°, K., YAMADA, T., KIMURA, M., OKA, T., OFISHIMA, H., and KONDO, T., Biophys. Chem., 1991, 41, (2), 175–183.
  • Microencapsulation of propranolol hydrochloride by the solvent evaporation technique. MANEKAR, N. C., PURANIK, P. K., and Josun, S. B., J. Microencapsul., 1992, 9, (1), 63–66.
  • Dynamic light scattering and fluorescence techniques reveal the mechanical properties of large unilamellar liposomes. MARANGONI, A. G., ERTEL, A., HALLETT, F. R., and WOOD, J. M., Biophys. J., 1992, 61, (2, Part 2), A243.
  • Dynamic light scattering and fluorescence techniques reveal the mechanical properties of large unilamellar liposomes. MARANGONI, A. G., ERTEL, A., HALLETT, F. R., and WOOD, J. M., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A243.
  • Nanocapsules of beta-blocking agents: a new drug carrier in ophthalmology. Application to medical treatment of glaucoma in rabbits. MARCHAL-HEUSSLER, L., S1RBAT, D., HOFFMAN, M., and MA1NCENT, P., J. Fr. Ophtalmol., 1991, 14, (6-7), 371–375.
  • Therapeutic effects of liposomal adriamycin in combination with tumor necrosis factor-alpha. MARUO, Y., KONNO H., and BABA, S., J. Surg. Oncol., 1992, 49, (1), 20–24.
  • Proteins and peptides bound to long-circulating liposomes. MARUYAMA, K., Mom, A., BHADRA, S., SUBBIAH, M. T., and HUANG, L., Biochim. Biophys. Acta, 1991, 1070, (1), 246–252.
  • Microencapsulated hepatocytes. Prospects for extracorporeal liver support. MATTHEW, H. W., SALLEY, S. 0., PETERSON, W. D. JR, DESHMUKH, D. R., MUKHOPADHYAY, A., and KLEIN, M. D., ASAIO Trans., 1991, 37, (3), M328–M330.
  • Poly(diethylmethylidene malonate) nanoparticles as a primaquine delivery system to liver.
  • MBELA, T. K. M., POUPAERT, J. H., and DUMONT, P., Int. J. Pharm., 1992, 79, (I), 29–38. Effect of lipid physical state on the rate of peroxidation of liposomes. MCCLEAN, L. R., and
  • HAGAMAN, K. A., Free Radical Biol. Med., 1992, 12, (2), 113–119.
  • Implanted synthetic dopamine (DA)-containing microspheres stimulate growth of DA fibers in rats with experimental hemi-Parkinsonism. MCCRAE, A., HJORTH, S., DAHLSTROEM, A., DILLoN, L., MASON, D., and TICE, T., Soc. Neurosci. Abstr., 1991, 17, (1-2), 770.
  • Microencapsulated dopamine (DA)-induced restitution of function in 6-0HDA-denervated rat striatum in vivo: comparison between two microsphere excipients. McRAE, A., HJORTH, S., MASON, D. W., DILLON, L., and TICE, T. R., J. Neural. Transplant. Plast., 1991,2, (3-4), 165–173.
  • First example of liposomes in a solvent other than water. MELIANI, A., PEREZ, E. Rico, I., LATTEs, A., and MOISAND, A., New J. Chem., 1991, 15, (12), 871–872.
  • Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treat-ment of experimental Klebsiella pneuntoniae infection. MELISSEN, P. M., VAN VIANEN, W. RIJSBERGEN, Y., and BAKKER-WOUDENBERG, I. A., Infect. Immun., 1992, 60, (1), 95–101.
  • A new drug approach to encapsulating non-steroidal anti-inflammatory drugs. V. Bio-pharmaceutical study of microcapsules of azapropazone coated with pectin and rutin. MESHALI, M. M., EL DIEN, E. Z., OMAR, S. A., and Luzzl, L. A., J. Microencapsul., 1992, 9, (1), 67–72.
  • Targeting and controlled release of antigens for the effective induction of secretory antibody responses. MESTECKY, J., and ELDRIDGE, J. H., Curr. Opin. Immunol., 1991, 3, (4), 492–495.
  • Liposomal amphotericin B (AmBisome): safety data from a phaseclinical trial. MEUNIER, F., PRENTICE, H. G., and RINGDEN, 0., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 83–91. Residual activity of microencapsulated permethrin against stable flies on lactating dairy
  • COWS. MEYER, J. A., and HUNTER, J. S., Med. Vet. Entomol., 1991, 5, (3), 359–362.
  • Organ distribution of liposomal formulations following intracarotid infusion in rsts. Micxurs, M. J., GREIG, N. H., TUNG, J., and RAPAPORT, S. I., Biochim. Biophys. Acta, 1992, 1124, (1), 7–12.
  • On the interaction of the liposomal membrane with blood components. MILLER, I. F., HOAG, J. M., and ROONEY, M. W., Biomater. Arti f. Cells Immobilization Biotechnol., 1991, 19, (2), 441.
  • Enhanced computed tomographic images of liver and spleen role of contrast agents encapsulated within interdigitation-fusion vesicles (IFVs). MINCHEY, S. R., PERKINS, W. R., AHL, P. L., SLATER, J. L., SELTZER, S. E., BLAU, M., ADAMS, D. S., and JANoFF, A. S., Biophys. J., 1992, 61, (2, Part 2), A447.
  • Enhanced computed tomographic images of liver and spleen role of contrast agents encapsulated within interdigitation-fusion vesicles (IFVs). MINCHEY, S. R., PERKINS, W. R., AHL, P. L., SLATER, J. L., SELTZER, S. E., BLAU, M., ADAMS, D. F., and JANOFF, A. S., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A447.
  • Fusion of outer mitochondrial membrane-containing liposomes in planar bilayer electrical properties of single and multi-channel membranes. MIRZABEKOV, T. A., BALLARIN, C., and SORGATO, M. C., Biophys. J., 1992, 61, (2, Part 2), A15.
  • Fusion of outer mitochondrial membrane-containing liposomes in planar bilayer electrical properties of single and multi-channel membranes. MIRZABEKOV, T. A., BALLARIN, C., and SORGATO, M. C., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A15.
  • Lipid peroxidation of lecithin liposomes depressed by some constituents of propolis. Misic, V., ONDRIAS, K., GERGEL, D., BULLOVA, D., SUCHY, V., and NAGY, M., Fitoterapia, 1991, 62,(3), 215–220.
  • Inhibition of lipid peroxidation of lecithin liposomes kept in a p11-stat system near neutral pH. MISIK, V., SVAJDLENKA, E., FILIPEK, J., GERGEL, D., and ONDRIAS, K., Free Radic. Res. Commun., 1991, 15, (3), 159–165.
  • Effects of differently composed liposomes on pulmonary arterial pressure in sheep-involvement of pulmonary intravascular macrophages. MIYAMOTO, K., NAKANO, T., Aol, K., AIDA, A., and KAWAKAMI, Y., Nippon Kyobu Shikkan Gakkai Zasshi, 1991, 29, (10), 1268–1274.
  • Phagocytosis of microspheres by granulocytes and cell recognition. MIYAMOTO, M., SASAKAWA, S., MIKAMI, Y., KAWAGUCHI, H., and OHTSUKA, Y., Maku, 1991, 16, (3), 151–162.
  • Lipid microspheres and lecithinized-polymer drug delivery systems. MIZUSHIMA, Y., and IGARASHI, R., In: R. L. Dunn, and R. M. Ottenbrite (Eds). ACS (America Chemical Society) Symposium Series, 469. Polymeric Drugs and Drug Delivery Systems; American Chemical Society: Washington, DC, USA. 1991, pp. 226–274.
  • Purification and characterization of liposomes encapsulating hemoglobin as potential blood substitutes. MOBED, M., NISHIYA, T., and CFIANG, T. M. S., Biomater. Artif . Cells Immobilization Biotechnol, 1992, 20, (1), 53–70.
  • Preparation and surface characterization of carboxymethylchitin-incorporated liposomes encapsulating hemoglobin. MOBED, M., NISHIYA, T., and CFIANG, T. M. S., Immobilization biotechnol., 1991, 19, (2), 442.
  • Preparation and surface characterization of carboxymethyl chitin-incorporated submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin. MOBED, M., and CHANG, T. M. S., Biomater. Artif. Cells, Immobilization Biotechnol., 1991, 19, (4), 731–744.
  • Decreased serum level of tumor necrosis factor in animals treated with lipopolysaccharide and liposomes containing phosphatidylserine. MONASTRA, G., and BRum, A., Ly,-nphokine Cytokine Res., 1992, 11, (1), 39–43.
  • Photosensitive liposomes as potential drug delivery vehicles for photodynamic therapy. MORGAN, C, G., MITCHELL, A. C., and CHOWDHARY, R. K., Proc. SPIE-Int. Soc. Opt. Eng., 1991, 1525 (Future Trends Biomed. Appl. Lasers), 391–396.
  • Use of photosensitive, antibody directed liposomes to destroy target populations of cells in bone marrow: a potential purging method for autologous bone marrow transplantation. MORGAN, J., MACROBERT, A. J., GRAY, A. G., and HUEHNS, E. R., Br. J. Cancer, 1992, 65, (1), 58–64.
  • Anticonvulsant effect of systemically administered gamma-aminobutyric acid (GABA)-containing liposomes in rats induced to seizure by amygdaloid electrical stimulation. Mom, N., SATO, T., and KUMASHIRO, H., J. Liposome Res., 1991, 2, (1), 49–55.
  • Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. MORISHITA, I., MORISHITA, M., TAKAYAMA, K., MACHIDA, Y., and NAGAI, T., Int. J. Pharm., 1992, 78, (1), 9–16.
  • Novel oral microspheres of insulin with protease inhibitor protecting from enzymic degrad-ation. MORISHITA, M., MORISHITA, I., TAKAYAMA, K., MACHIDA, Y., and NAGAI, T., Int. J. Pharm., 1992, 78, (1), 1–7.
  • The effect of block co-polymers on the uptake of model polystyrene microspheres by Kupffer cells in vitro and in vivo studies. MUIR, I. S., MOGHIMI, S. M., ILLum, L., DAVIS, S. S., and DAVIES, M. C., Biochem. Soc. Trans., 1991, 19, (3), 329S.
  • Polymeric microspheres for radionuclide synovectomy containing neutron-activated holmium-166. MUMPER, R. J., MILLS, B. J., RYO, U. Y., and JAY, M., J. Nucl. Med., 1992, 33, (3), 398–402.
  • Poly(L-lactic acid) microspheres containing neutron-activatable holmium-165: a study of the physical characteristics of microspheres before and after irradiation in a nuclear reactor. MUMPER, R. J., and JAY, M., Pharm. Rec., 1992, 9, (1), 149–154.
  • Neutron-activated holmium-166-poly(t-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors. MUMPER, R. J., RYO, U. Y., and JAY, M., J. Nucl. Med., 1991, 32, (11), 2139–2143.
  • Design of liposomes for circumventing the reticuloendothelial cells. MUMTAZ, S., GHOSH, P. C., and BACHHAWAT, B. K., Glycobiology, 1991, 1, (5), 505–510.
  • Accessory sperm numbers for cattle inseminated with protamine sulfate microcapsules.
  • MUNKITTRICK, T. W., NEBEL, R. L., and SAACKE, R. G., J. Dairy Sci., 1992, 75, (3), 725–731. Advanced technology of polymeric microspheres. MUROI, S. (Ed.). CMC Co., Ltd, Tokyo, Japan, 1991, 294 pp.
  • Surfactant-induced release from phosphatidylcholine vesicles. Regulation of rupture and leakage pathways by membrane packing. NAGAWA, Y., and REGAN, S. L., J. Am. Chem. Soc., 1992, 114, (5), 1668–1672.
  • Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. NAIR, S., ZHOU, F., REDDY, R., HUANG, L., and ROUSE, B. T., J. Exp. Med., 1992, 175, (2), 609–612.
  • Application of lipid microspheres to prepare a thromboxane A' antagonist S-1452 inhaler. NAKAGAWA, T., TAKENAGA, M., IGARASHI, R., NAKAJIMA, T., and MIZUSHIMA, Y., J. Allergy Clin. Immunol., 1992, 89, (1, Part 2), 235.
  • Phospholipids in clinical applications. NAMBA, Y., and ORE, N., Drug Delivery Syst., 1991, 6, (5), 339–348.
  • In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. NASSANDER, U. K., STEERENBERG, P. A., POPPE, H., STORM, G., POELS, L. G., DE JONG, W. H., and CROMMELIN, D. J., Cancer Res., 1992, 52, (3), 646–653.
  • Microencapsulates in textile coloration and finishing. NELSON, G., Rev. Prog. Color Relat. Top., 1991, 21, 72–85.
  • An enzyme inhibition assay for the study of the association of negatively charged liposomes with cells at nanomolar lipid concentration. NG, L. K. Y., University of Wisconsin, Madison, WI, USA, Dissertation, 1991, 182 pp.
  • Carboxyacyl derivatives of cardiolipin as four-tailed hydrophobic anchors for the covalent coupling of hydrophilic proteins to liposomes. NIEDERMANN, G., WEISSIG, V., STERNBERG, B., and LASCH, J., Biochim. Biophys. Acta, 1991, 1070, (2), 401–408.
  • The use of liposomes as drug carriers in ophthalmology. NIESMAN, M. R., Cult. Rev. Ther. Drug Carriers Syst., 1992, 9, (1), 1–38.
  • The effect of liposome encapsulated MDP on the tumoricidal properties of mouse macro-phages. NING XIAOPING and ZHU TIANXIAO, Zhongguo Yike Daxue Xuebao, 1991, 20, (5), 329–332.
  • A study of embolizing materials for chemo-embolization therapy of hepatocellular car-cinoma: embolic effect of cisplatin albumin microspheres using chitin and chitosan in dogs and changes of cisplatin content in blood and tissue. NISHIOKA, Y., KYOTANI, S., OKAMURA, M., MIYAZAKI, M., SAKAMOTO, Y., MORITA, M., OKAZAKI, I. K., OHNISHI, S., YAMAMOTO, Y., and IT°, K., Chem. Pharm. Bull., 1992, 40, (1), 267–268.
  • Phospholipid liposomes: preparation, characterization, and uses. NORDMEIER, E., ZEILINGER, C., and LECHNER, M. D., J. Appl. Polym. Sci., 1992, 44, (3), 533–544.
  • Polymer-drug complexes in the treatment of extensive ovarian cancer. NOVIKOVA, E. G., BORISOV, V. I., DMITRIEV, D. G., ZEL'VIN, B. M., KARSELADZE, A. I., SHCHITKOV, K. G., and Li, A. D., Soy. Med., 1991, (11), 27–29.
  • Controlled release microparticles for vaccine development. O'HAcAN, D. T., JEFFERY, H., ROBERTS, M. J., MCGEE, J. P., and DAVIS, S. S., Vaccine, 1991, 9, (10), 768–771.
  • Effective incorporation of 2'-0-methyl-oligoribonucleotides into liposomes and enhanced cell association through modification with thiocholesterol. OBERHAUSER, B., and WAGNER, E., Nucleic Acids Res., 1992, 20, (3), 533–538.
  • Effects of combination of tumor necrosis factor alpha, and chemotactic peptide, f-Met-Leu-Phe, on phagocytosis of opsonized microspheres by human neutrophils. OGLE, J. D., NOEL, J. G., SRAMKOSKI, R. M., OGLE, C. K., and ALEXANDER, J. W., Inflammation, 1992, 16, (1), 57–68.
  • Simple coacervate of Pullulan formed by the addition of poly(ethylene oxide) in an aqueous solution. OHNO, H., and HIGANO, M., Polymer, 1991, 32, (16), 3062–3066.
  • Formulation factors affecting the efficacy, phytotoxicity, and rainfastness of fenitrothion microcapsules for agricultural use. OHTSUBO, T., TSUDA, S., TAKEDA, H., and Tsuji, K., Nippon Noyaku Gakkaishi, 1991, 16, (4), 609–614.
  • Growth inhibition of tumour cells by a liposome-encapsulated, mycolic acid-containing glycolipid, trehalose 2,3,6'-trimycolate. OHTSUBO, Y., FURUKAWA, M., IMAGAWA, T., SUGIMOTO, N., IKUTOH, M., NAKATSUGI, S., KATOH, Y., SHINKA, S., and DOH, Y., Immunology, 1991, 74, (3), 497–503.
  • Changes in surface charge density of lecithin liposomes by lipid peroxidation: a fluorescence study with 8-anilino-1-naphthalenesulfonate. OHYASHIKI, T., ADACHI, R., and MATSUI, K., Chem. Pharm. Bull., 1991, 39, (12), 3295–3298.
  • An analysis of first-order release kinetics from albumin microspheres. OKADA, J., MASUYAMA, Y., and KoNoo, T., J. Microencapsul., 1992, 9, (1), 9–18.
  • Liposomes. Oxu, N. In: Dunn, R. L., and Ottenbrite R. M. (Eds). ACS (American Chemical Society) Symposium series, 469, Polymeric Drugs and Drug Delivery Systems; American Chemical Society: Washington, DC, USA. 1991, pp. 24–33.
  • Liposome membrane. Oxu, N., Rinsho Byori, Rinji Zokan, 1991, 91, 225–237.
  • Studies on suspension and emulsion. CXXVIII. Production of multi-hollow polymer micro-spheres by stepwise alkali/acid method. II. Alkali treatment process. OKUBO, M., ICHIKAWA, K., and FujiMURA, M., Colloid Polym. Sci., 1991, 269, (12), 1257–1261.
  • Comparison of dynamics of lecithin liposomes and brain total lipid liposomes with synap-tosomal membranes. An EPR spectroscopy study. ONDRIAS, K., STASKO, A., Mimic, V., and SVAJDLENKA, E., Gen. Physiol. Biophys., 1991, 10, (4), 411–420.
  • The chloride-sensitive fluorescent indicator SPQ responds to buffer anions and provides a sensitive assay for proton transport in liposomes. OROSZ, D. E., and GARLID, K. D., Biophys. J., 1992, 61, (2, Part 2), A311.
  • The chloride-sensitive fluorescent indicator SPQ responds to buffer anions and provides a sensitive assay for proton transport in liposomes. OROSZ, D. E., and GARLID, K. D., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A311.
  • Lessons learned from studies on tumor suppression by microcell-mediated chromosome transfer. OSHIMURA, M., Environ. Health Perspect., 1991, 93, 57–58.
  • Multiple chromosomes carrying tumor suppressor activity, via microcell-mediated chromo-some transfer, for various tumor cell lines. OSHIMURA, M., Kuooh, H. M., Shimizu, M., YAMADA, H., HASHIBA, H. HORIICAWA, I., and SASAKI, M., Proc. Int. Symp. Princess Takamatsu Cancer Res. Fund, 1989, 20, (Genet. Basis Carcinog.), publ. 1990, pp. 249–257.
  • Complete substitution of microscapsules for algae for Penaeus stylirostris larval rearing in New Caledonia. OTTOGALLI, L., J. World-Aquacult. Soc., 1991, 22, (3), 46A.
  • Stabilization of liposomes with collagen. PAJEAN, M., Huc, A. and HERBAGE, D., Int. J. Pharm., 1991, 77, (1), 31–40.
  • Pharmacokinetics of 5-fluorouracil nanocapsules. PAN WE1SAN and Hu JiN, Shenyang Yaoxueyuan Xuebao, 1991, 8, (3), 157–160.
  • Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeu-tic efficacy. PAPAHADJOPOULOS, D., ALLEN„ T. M., GABIZON, A., MAYHEW, E., MATTHAY, K., HUANG, S. K., LEE, K. D., WOODLE, M. C., LASIC, D. D., REDEMANN, C. et al., Proc. Natl. Acad. Sci. USA, 1991, 88, (24), 11460–11464.
  • Serum opsonins and liposomes: their interaction and opsonophagocytosis. PATEL, H. M., Crit. Rev. Ther. Drug Carriers Syst., 1992, 9, (1), 39–90.
  • Two-dimensional crystallization of a bacterial surface protein on lipid vesicles under controlled conditions. PAUL, A., ENGELHARDT, H., JAKUBOWSKI, U., and BAUMEISTER, W., Biophys. J., 1992, 61, (1), 172–188.
  • Effect of gelatin properties in complex coacervation processes. PETERS, H. J. W., VAN BOMMEL, E. M. G., and FOKKENS, J. G., Drug Dev. Ind. Pharm., 1992, 18, (1), 123–134.
  • Xenotransplantation of microencapsulated pancreatic islets contained in a vascular pros-thesis: preliminary results. PETRUZZO, P., PIBIRI, L., DE GUIDICI, M. A., BASTA, G., CALAFIORE, R., FALORNI, A., BRUNETTI, P., and BROTZU, G., Transpl. Int., 1991, 4, (4), 200–204.
  • Immunogenicity of immunoliposomes. PHILLIPS, N. C., and Emmi, A., Immunol. Lett., 1991, 30, (3), 291–296.
  • Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome. PHILLIPS, N. C., and TSOUKAS, C., Blood, 1992, 79, (5), 1137–1143.
  • Liposomal encapsulation of 3'-azido-3'-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosup-pression. PHILLIPS, N. C., SKAMENE, E., and TSOUKAS, C., J. Acquired Immune Defic. Syndr., 1991, 4, (10), 959–966.
  • Bioclistribution studies of liposome encapsulated hemaglobin (LEH) studied with a newly developed technetium-99M liposome label. PHILLIPS, W. T., RUDOLPH, A. S., and KLIPPER, R., Immobilization Biotechnol., 1991, 19, (2), 463.
  • Thermodynamical characteristics and volume compressibility of dipalmitoylphosphatidyl-choline liposomes containing bacteriorhodopsin. PIKNOVA, B., HIANIK, T., SHESTIMIROV, V. N., and SHNYROV, V. L., Gen. Physiol. Biophys., 1991, 10, (4), 395–409.
  • Effect of various poloxamer coatings on in vitro adhesion of isohexyl cyanoacrylate nano-spheres to rat ileal segments under liquid flow. PIMIENTA, C., CHOUINARD, F., LABIB, A., and LENAERTS, V., Int. J. Pharm., 1992, 80, (1), 1–8.
  • Stable target-sensitive immunoliposomes. PINNADUWAGE, P., and HUANG, L., Biochemistry, 1992, 31, (11), 2850–2855.
  • Intraocular availability of liposome encapsulated monoclonal antibodies in the rabbit model. Results of a pilot study. PLEYER, U., RUCKERT, D., BACHMANN, W., SCHMIDT, K. H., and THIEL, H. J., Fortschr. Ophthalmol., 1991, 88, (6), 870–874.
  • Interaction of cyclosporin A with liposomes and lipid membranes. POLIKANDRITOU, M., University of Minnesota, Minneapolis, MN, USA, Dissertation, 1991, 225 pp.
  • Antioxidative activity of synthetic melanins. Cardiolipin liposomes model. PORCEBSKA-BUDNY, M., SAKINA, N. L., STCEPIEN, K. B., DONTSOV, A. E., and WiLuzox, T., Biochim. Biophys. Acta, 1992, 1116, (1), 11–16.
  • A comparison of the physicochemical characteristics of poloxamer coated polystyrene microspheres with their in vitro uptake by liver cells. PORTER, C. J. H., MOGHIMI, S. M., ILLUM, L., DAVIES, M. C., and DAVIS, S. S., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 82P.
  • Continuous solidification/stabilization processing of hazardous wastes through polymeric microencapsulation. POWELL, M. R., and MAHALINGAM, R., Ind. Eng. Chem. Res., 1992,31, (2), 543–549.
  • Treatment of invasive fungal infection in patients with leukemia by liposomal amphotericin B. PRENTICE, H. G., Onkologie, 1991, 14, (Suppl. 2), 127–128.
  • Interaction of liposomes with erythrocytes in the process of their lysis. PRIMAK, R. G., MAKSIMOV, Yu. N., GoLusov, M. I., and LEBED, 0. I., Ukr. Biokhim. Zh., 1991, 63, (6), 78–83.
  • Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in odents. PROFFITT, R. T., SATORIUS, A., CHIANG, S. M., SULLIVAN, L., and ADLER MOORE, J. P., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 49–61.
  • Study of abietic acid glycerol derivatives as microencapsulating materials. PURANIK, P. K., and DORLE, A. K., J. Microencapsul., 1991, 8, (2), 247–252.
  • Use of deacetylated gellan gum (Gelrite) for the production of sulfamethizole-containing beads. QUIGLEY, K. J., and DEASY, P. B., J. Microencapsulation, 1992, 9, (1), 1–7.
  • Effect of liposome encapsulated hemaglobin (LEH) on adhesiveness of human umbilical vein endothelial cells (HUVEC) for monocytic U937 cells. RABINOVICI, R., SUNG, C. P., RUDOLPH, A. S., and FEUERSTEIN, G., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (2), 470.
  • The study on drug microforms. XXII. Matrix tablets with xanthinolium nicotinate from polyacrylate microcapsules. RAK, J., and VITKOVA, M., Farm. Obz., 1991, 60, (4), 161–172.
  • Differential susceptibility of phosphatidylcholine small unilamellar vesicles to phospholi-pases A2, C and D in the presence of membrane active peptides. RAO, N. M., Biochem. Biophys. Res. Commun., 1992, 182, (2), 682–688.
  • Studies on the mechanism of the hematoporphyrin-sensitized photooxidation of 1,3-diphenyl-isobenzofuran in ethanol and unilamellar liposomes. REDDI, E., VALDUGA, G., RODGERS, M. A., and Joni, G., Photochem. Photobiol., 1991, 54, (4), 633–637.
  • In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. REDDY, R., ZHOU, F., NAIR, S., HUANG, L., and ROUSE, B. T., J. Immunol., 1992, 148, (5), 1585–1589.
  • Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. RINGDEN, 0., MEUNIER, F., TOLLEMAR, J., RICCI, P., TURA, S., KUSE, E., VIVIAN, M. A., GORIN, N. C., KLASTERSKY, J., FENAUX, P., et al., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 73–82.
  • Liposomal amphotericin B (letter). RINGDEN, 0., TOLLEMAR, J., and TYDEN, G., Lancet, 1992, 339, (8789), 374.
  • Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice. RIONDEL, J., JACROT, M., FESSI, H., PUISIEUX, F., and POTIER, P., In Vivo, 1992,6, (1), 23–27.
  • Effect of penetration enhancers on the phase transition of multilamellar liposomes of dipalmitoylphosphatidylcholine. A study by differential scanning calorimetry. ROLLAND, A., BRZOKEWICZ, A., SHROOT, B., and JAMOULLE, J. C., Int. J. Pharm., 1991,76, (3), 217–224.
  • Oligonucleotides encapsulated in pH sensitive liposomes are efficient towards Friend retrovirus. ROPERT, C., LAVIGNON, M., DUBERNET, C., COUVREUR, P., and MALVY, C., Biochem. Biophys. Res. Commun., 1992, 183, (2), 879–885.
  • A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. ROSE, J. K., BUONOCORE, L., and WHITT, M. A., BioTechniques, 1991, 10, (4), 520–525.
  • A liposomal enzyme electrode for measuring glucose. ROSENBERG, M. F., JONES, M. N., and VADGAMA, P. M., Biochim. Biophys. Acta, 1991, 1115, (2), 157–165.
  • Liposomes, advantages in manufacturing technology and therapy. RuBAS, W., and SCHREIER, H., Pharm. Unserer Zeit., 1991, 20, (6), 255–270.
  • Liposome encapsulated hemoglobin: in vivo efficacy of a synthetic red cell substitute. RUDOLPH, A. S., GOINS, B., L1GLER, F., CLIFF, R. 0., SPIELBERG, H., HOFFMAN, P., PHILLIPS, W., and KLIPPER, R. In: J. C. Gomez-Fernandez, D. Chapman and L. Packer (Eds). Advances in Life Sciences: Progress in Membrane Biotechnology. 340P. Birkhaeuser Verlag: Basel, Switzerland; 1991, pp. 214–226.
  • Liposome encapsulated bovine hemoglobin: circulation, persistence, biodistribution, hemo-dynamics and long-term storage. RUDOLPH, A. S., RABINOVICI, R., FEURSTEIN, G., L1GLER, F. S., GOINS, B., CLIFF, R., KLIPPER, R., and PHILLIPS, W., Biomater. Artif. Cells Immobilization Biotechnol, 1991, 19, (2), 478.
  • In vivo biodistribution of a radiolabeled blood substitute: technetium-99m-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. RUDOLPH, A. S., KLIPPER, R. W., GOINS, B., and PHILLIPS, W. T., Proc. Natl. Acad. Sci. USA, 88, (23), 10976–10980.
  • Effect of calcium channel blockers on platelet GPIIB-IIIA as a calcium channel in liposomes: comparison with effects on the intact platelet. RYBAK, M. E. M., and RENZULLI, L. A., Thromb. Haemostasis, 1992, 67, (1), 131–136.
  • Testing microencapsulated combustion inhibitors in epoxy sealing compound. SAMOKHVALOV, E. P., RILO, R. P., ZAVERACH, M. M., STEKLOVA, V. V., SIIIKHANOVA, L. N., and SERGEEVA, T. M., Bromorgan Soed i Antipireny Sintez, Svoistva, Metody Anal i Perspektivy Ispez Krym NPO lodobrom', Cherkassy, 1991, 41–45.
  • Preparation and characterization of biodegradable poly(L-lactic acid) gentamicin delivery systems. SAMPATH, S. S., GARVIN, K., and ROBINSON, D. H., Int. J. Pharm., 1992,78, (2-3), 165–174.
  • Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres. SANDERS, W. E. JR, CHEIRIF, B. J., DESIR, R., ZOGHBI, W. A., HOYT, B. D., Smut2, P. E., and QUINONES, M. A., Am. Heart. J., 1992, 122, (6), 1660–1665.
  • The effect of doxorubicin on the transport of glutathione conjugates from human erythrocytes. SAXENA, M., SHARMA, R., SINGHAL, S. S., AHMAD, H., and AWASTHI, Y. C., Biochem. Arch., 1991, 7, (4), 285–292.
  • In vivo behavior of liposomes: interactions with the mononuclear phagocyte system and implications for drug targeting. SCHERPHOF, G. L., Handb. Exp. Pharmacol., 1991, 100 (Targeted Drug Delivery), 285–327.
  • Esterification of short chain organic acids with alcohols by a lipase microencapsulated in reversed micelles. SCHLATMANN, J., AIRES-BARROS, M. R., and CABRAL, J. M. S., Biocatalysis, 1991, 5, (2), 137–144.
  • Liposomal amphotericin B for the treatment of invasive mycosis in immunocompromised patients: safety evaluation and tissue pharmacokinetics. SCHROYENS, W., and PRALLE, H., Onkologie, 1991, 14, (Suppl. 2), 149–150.
  • Directed lysis of experimental cancer by beta-carotene in liposomes. SCHWARTZ, J. L., FLYNN, E., TRICKLER, D., and SHKLAR, G., Nutr. Cancer, 1991, 16, (2), 107–124.
  • Overcoming murine tumor cell resistance to vinblastine by presentation of the drug in multilamellar liposomes consisting of phosphatidylcholine and phosphatidylserine. SEID, C. A., FIDLER, I. J., CLYNE, R. K., EARNEST, L. E., and FAN, D., Sel. Cancer Ther., 1991,7, (3), 103–112.
  • New prospects in the development of liposomes, II. Therapeutic applications. SEIjo-REv, B., GUTIERREZ DE RUBALCAVA, C., and VILA-J.4TO, J. L., Farm. C/in., 1991,8, (7), 601–603. 607–610. 612–613.
  • New prospects in the development of liposomes. I. Technological aspects. SEijo-REy, B., GURIERREZ DE RUBALCAVA, C., and VILA-JATO, J. L., Farm. C/in., 1991, 8, (6), 516–526.
  • Interaction of positively-charged liposomes with blood: implications for their application in vivo. SENIOR, J. H., TRIMBLE, K. R., and MASKIEWICZ, R., Biochim. Biophys. Acta, 1991, 1070, (1), 173–179.
  • Channel reconstitution in liposomes and planar bilayers with HPLC-purified MIP26 of bovine lens. SHEN, L., SHRAGER, P., GIRSCH, S. J., DONALDSON, P. J., and PERACCHIA, C., J. Membr. Biol., 1991, 124, (1), 21–32.
  • Release kinetics of drugs from rosin-glycerol ester microcapsules prepared by solvent evaporation techniques. SHEOREY, D. S., and DORLE, A. K., J. Microencapsul, 1991,8, (2), 243–246.
  • Protective effects of liposomal superoxide dismutase in rat brain. SHIN DONG JIN, BAEK KWANG JIN and LEE HI SUNG, Chungang Uidaechi, 1990, 15, (4), 329–336.
  • A method to analyze the surface of microcapsules using diffuse reflectance. SHIVELY, M. L., LAVIGNE, G., and SIMONELLI, P., Drug Dev. Ind. Pharm., 1991, 17, (18), 2511–2519.
  • Effect of drug loading and molecular weight of cellulose acetate propionate on the release characteristics of theophylline microspheres. SHUKLA, A. J., and PRICE, J. C., Pharm. Res., 1991, 8, (11), 1396–1400.
  • Study of the effect of polybuty1-2-cyanoacrylate nanoparticles and comparative investigation of the effect of free and included into polybutylcyanoacrylate nanoparticles vinblastine on some hematologic indices in mice. SIMEONOVA, M., TVANOVA, Ts., and KONSTANTINOV, Probl. Onkol., 1990, 18, 12–18.
  • Efficacy of a topical liposomal formulation of the H-1-receptor antagonist H-1-RA hydroxyzine H in an animal model. SIMONS, K. J., SIMONS, F. E. R., MA, Q., NAAS, F., and VENKATARAM, S., J. Allergy Clin. Immunol., 1992, 89, (1, Part 2), 249.
  • Effect of membrane cholesterol on calcium phosphate formation in aqueous suspensions of anionic liposomes. SKRTIC, D., and EANES, E. D., Calcif. Tissue Int., 1992, 50, (1), 55–60.
  • Membrane-mediated precipitation of calcium phosphate in model liposomes with matrix vesicle-like lipid composition. SKRTIC, D., and EANES, E. D., Bone Miner., 1992, 16, (2), 109–119.
  • Effect of different phospholipid-cholesterol membrane compositions on liposome-mediated formation of calcium phosphates. SKRTIC, D., and EANES, E. D., Cakif. Tissue Int., 1992, 50, (3), 253–260.
  • The in situ immune response of the rat after intraperitoneal depletion of macrophages by liposome-encapsulated dichloromethylene diphosphonate. SOESATYO, M., BIEWENGA, J., VAN RootiEN, N., KORS, N., and SMINIA, T., Res. Immunol., 1991, 142, (7), 533–540.
  • Liposomal amphotericin B (AmBisome) in the treatment of systemic fungal infection. Based on Papers Presented at a Symposium in Stratford-on-Avon, UK, March 1991 (In: J. Antimicrob. Chemother.). SPELLER, D. C. E., WARNOCK, D. W., and DALY, P. J. (Eds). Academic Press, London, UK, 1991, 118 pp.
  • Lipofectin direct gene transfer to higher plants using cationic liposomes. SPOERLEIN, B., and KOOP, H. U Theor. Appl. Genet., 1991, 83, (1), 1–5.
  • Human serum induced opsonization of immunoglobulin G-coated polystyrene microspheres with complement components C3 and C4 as measured by flow cytometry. SPYCHER, M. 0., SPYCHER-BURGER, M., SPATH, P. J., and BURCKHARDT, J. J., J. Immunol. Methods, 1991, 145, (1-2), 83–92.
  • Mobilization of cadmium by liposome-encapsulated meso-2,3-dimercaptosuccinic acid in pre-exposed mice. SRIVASTAVA, S., GUPTA, S., BEHARI, J. R., and SRIVASTAVA, R. C., Toxicol. Lett., 1991, 59, (1-3), 125–131.
  • Microcell mediated chromosome transfer and interphase cytogenetics, a strategy for mapping the Zellweger syndrome genes. STANLEY, W., DEVINE, G., and ELLINGFIAM, T., Am. J. Hum. Genet., 1991, 49, (4, Suppl.), 371.
  • Intracerebral administration of alpha tocopherol-containing liposomes facilitates behavioral recovery in rats with bilateral lesions of the frontal cortex. STEIN, D. G., HALKS-MILLER, M., and HOFFMAN, S. W., J. Neurotrauma, 1991, 8, (4), 281–292.
  • Treatment of tumors using cytostatic-containing liposomes. STORM, G., NASSUNDER, U. K., STEERENBERG, P. A., and CROMMELIN, D. J. A. In J. C. Gomez-Fernandez, D. Chapman and L. Packer (Eds). ._dvances in Life Sciences: Progress in Membrane Biotechnology. 340P. Birkhaeuser Verlag, Basel, Switzerland; 1991, pp. 203–213.
  • Preparation of encapsulated microbial cells for environmental applications. STORMO, K. E., and CRAWFORD, R. L., Appl. Environ. Microbiol., 1992, 58, (2), 727–730.
  • Inhibition of immune reactions in vivo by liposome associated transforming growth factor (TGF) type beta 1. STRASSMANN, G., BERTOLINI, D. R., and EIDELMAN, 0., C/in. EXP. innnlin0/., 1991, 86, (3), 532–536.
  • Drug-containing liposomes, a target-oriented drug form for the therapy of special cancer diseases. STRICKER, H., HERRMANN, J., KREMPEL, H., KROTZ, R., MENTRUP, E., WECKENMANN, H. P., MATZKU, S., WOWRA, B., and ZELLER, W. J., PZ Wiss., 1991, 4, (5-6), 209–213.
  • Properties of methotrexate-containing liposomes for intratumoral application. STRICKER, H., MENTRUP, E., KROTZ, R., ZELLER, W. J., STURM, V., and WOWRA, B., Eur. J. Pharm. Biopharm., 1991, 37, (3), 175–177.
  • Liposomes as cyclosporin A carriers: ESA study of cyclosporin A interaction with 1,2-dimyristoyl-sn-3-phosphatidylglycerol liposomes. STUHNE-SEKALEC, L., and STANACEV, N., J. Microencapsul., 1991, 8, (4), 455–463.
  • Liposomes as carriers of macrolides: preferential association of erythromycin A and azithromycin with liposomes of phosphatidylglycerol containing unsaturated fatty acid(s). STUHNE-SEKALEC, L., STANACEV, N. Z., and DJOKIC, S., Microencapsul., 1991,8, (2), 171–183.
  • The comparative study on the dissolution rate of aspirin after microencapsulation. SUN-RONGBO, DENG YANGI, ZHOU BAOLIN, ZHU ZAIREN, DUAN XINGYUN, and XIE YYNMIAO, Zhongguo Yiyuan Yaoxue Zazhi, 1991, 11, (10), 461–462.
  • Development and validation of a sterility test method for large, gentamicin-containing liposomes. SWENSON, C. E., REIFSNYDER, D. A., FRAZIER, D., and STEWART, K. A., J. Liposome Res., 1991, 2, (1), 43–48.
  • Study on a novel hyposensitization therapy using antigen containing biodegradable micro-spheres. TAKAGI, I., Nagoya-shiritsu Daigaku Igakkai Zasshi, 1991, 42, (2), 269–285.
  • The freeze-drying of liposome dispersions. TALSMA, H., STEENBERGEN, M. J. V., and CROMMELIN, D. J. A., Cryobiology, 1991, 28, (6), 589.
  • The cryopreservation of lipsomes: 3. Almost complete retention of a water-soluble marker in small liposomes in a cryoprotectant containing dispersion after a freezing/thawing cycle. TALSMA, H., VAN STEENBERGEN, M. J., and CROMMELIN, D. J. A., Int. J. Pharm., 1991,77, (2-3), 119–126.
  • The cryopreservation of liposomes. 2. Effect of particle size on crystallization behavior and marker retention. TALSMA, H., VAN STEENBERGEN, M. J., and CROMMELIN, D. J. A., Cryobiology, 1992, 29, (1), 80–86.
  • Interfacial polymerization encapsulation of a viscous pigment mix: emulsification conditions and particles size distribution. TAN, H. S., NG, T. H., and MAHABADI, H. K., J. Microencapsul., 1991, 8, (4), 525–536.
  • A study of the efficacy of liposomes in comparison to new and established adjuvants in potentiating the antibody response against hepatitis B virus surface antigen. TAN, L., Asian Pac. J. Allergy Immunol., 1991, 9, (2), 83–87.
  • A novel positively-charged lipid 1,2-bis(hexadecylcycloxy)-3-trimethyl aminopropane (BisHOP) enhances the adjuvant effect of liposomes on encapsulated tetanus toxoid. TAN, L., and GREGORIADIS, G., Asian Pac. J. Allergy Immunol., 1991, 9, (1), 21–24.
  • Comparison of the immune response against polio peptides covalently-surface-linked to and internally-entrapped in liposomes. TAN, L., WEISSIG, V., and GREGORIADIS, G., Asian Pac. J. Allergy Immunol., 1991, 9, (1), 25–30.
  • Cryprotective mechanism of saccharides on freeze-drying of liposome. TANAKA, K., TAKEDA, T., Fuji, K., and MIYAJIMA, K., Chem. Pharm. Bull., 1992, 40, (1), 1–5.
  • Freeze-drying of liposomes prepared by sonication and extrusion techniques. TANAKA, K., TAKEDA, T. Fujii, K., and MIYAJIMA, K., Chem. Pharm. Bull., 1991, 39, (10), 2653–2656.
  • Prevention of chronic pulmonary oxygen toxicity in young rats with liposome-encapsulated catalase administered intratracheally. THIBEAULT, D. W., REZMEKHALIGH, M., MABRY, S., and BERINGER, T., Pediatr. Pulmonol., 1991, 11, (4), 318–327.
  • Reconstitution of the tonoplast amino acid carrier into liposomes. Evidence for an ATP-regulated carrier in different species. THUME, M., and DIETZ, K. J., Planta, 1991, 185, (4), 569–575.
  • Liposomal formulation of diamidine: lower toxicity. TIMOFEEV, B. A., BOLOTIN, I. M., STEPANOVA, L. P., BOGDANOV, A. A., GHEORGHIU, H., MALYSHEV, S. N., PETROVSKII, V. V., KLIBANOV, A. L., and TORCHILIN, V. P., Antibiot. Khimioter., 1991, 36, (9), 34–36.
  • Three-dimensional analysis of inorganic microcapsules by submicron SIMS using a gallium focused ion beam. TomIYASU, B., SATOH, H., OWARI, M., and NIHEI, Y., Bunseki Kagaku, 1991, 40, (11), 629–633.
  • Effect of vitamin E-containing liposomes on the formation and progression of in vitro xylose cataract. TORII, H., OKADA, H., MAJIMA, Y., OHTA, Y., and ISHIGURO, I., Atarashii Ganka, 1991, 8, (10), 1647–1652.
  • Dyphylline liposomes for delivery to the skin. TOUITOU, E., SHACO-EZRA, N., DAYAN, N., JUSHYNSKI, M., RAFAELOFF, R., and AZOURY, R., J. Pharm. Sci., 1992, 81, (2), 131–134.
  • Doxorubicin-loaded nanospheres are able to circumvent multidrug resistance in vitro. TREUPEL, L., POUPON, M. F., COUVREUR, P., and PUISIEUX, F., C. R. Acad. Sci. Ser. III: Sci. Vie., 1991, 313, (3), 171–174.
  • Microsphere encapsulated levo ascorbic acid: its effects on erythrocytes during 56 days storage. TRUTER, E. J., Biomater. Aril Cells Immobilization Biotechnol., 1991, 19, (2), 493.
  • Preparation of tinidazol microspheres with polyacrylate resins. TSANKOV, S., LAMBOV, N., and MINKOV, E., Pharm. Ind., 1991, 53, (7), 695–698.
  • Polymerization of unsaturated phospholipids as large unilamellar liposomes at low tempera-ture. TSUCHIDA, E., HATASHITA, M., MAKINO, C., HASEGAWA, E., and KIMURA, N., Macro-molecules, 1992, 25, (1), 207–212.
  • Metabolic activity of CHO fibroblasts in HEMA-MMA microcapsules. ULUDAG, H., and SEFTON, M. V., Biotechnol. Bioeng., 1992, 39, (6), 672–678.
  • Development of a new diagnostic assay system using liposomes. UMEDA, M., Rinsho Byori, 1991, 91, 249–260.
  • Reconstitution of glucosylceramidase into acidic phospholipid-containing liposomes. VACCARO, A. M., SALVIOLI, R., CIAFFONI, F., and TATTI, M., Am. J. Hum. Genet., 1991, 49, (4, Suppl.), 108.
  • Reconstruction of glucosylceramidase on bonding to acidic phospholipid-containing vesicles. VACCARO, A. M., TATTI, M., CIAFFONI, F., SALVIOLI, R., and RONCAIOLI, P., Biochim. Biophys. Acta, 1992, 1119, (3), 239–246.
  • Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporine. VADIEI, K., LOPEZ BERESTEIN, G., PEREZ, S. R. and LUKE, D. R., Drug Metab. Dispos., 1991, 19, (6), 1147–1151.
  • Particle sizing of liposomal dispersions: a critical evaluation of some quasi-elastic light-scattering data-analysis software programs. VAN DER MEEREN, P., VAN LAETHEM, M., VANDERDEELEN, J., and BAERT, L., J. Liposome Res., 1991, 2, (1), 23–42.
  • The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres. VANDELLI, M. A., FORM, F., IANNUCCELLI, V., and CAMERONI, R., J. Pharm. Belg., 1991, 46, (6), 381–388.
  • Magainins and liposomal systems effect of net membrane charge and transmembrane potential. VAZ GOMES, A., DE WAAL, A., BERDEN, J. A., and WESTERHOFF, H. V., Biophys. J., 1992, 61, (2, Part 2), A113.
  • Magainins and liposomal systems' effect of net membrane charge and transmembrane potential. VAZ GOMES, A., DE WAAL, A., BERDEN, J. A., and WESTERHOFF, H. V., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A113.
  • Rapid loss and restoration of lipid asymmetry by different pathways in resealed erythrocyte ghosts. VERHOVEN, B., SCHLEGEL, R. A., and WILLIAMSON, P., Biochim. Biophys. Acta, 1992, 1104, (I), 15–23.
  • Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin. VERRIJK, R., SMOLDERS, I. J., McV1E, J. G., and BEGG, A. C., Cancer Chemother. Pharmacol., 1991, 29, (2), 117–121.
  • Liposomal amphotericin B (letter). VINCENT, M., WEBSTER, M. H., and PETHER, J. V., Lancet, 1992, 339, (8789), 374–375.
  • Cytoxicity of inflammatory mediators secreted around microencapsulated cells. VITIELLO, S., CADIC, C., and DUPUY, B., C.R. Seances Soc. Biol. Fil., 1991, 185, (5), 338–344.
  • Immunoprotection obtained with microcapsules does not prevent cytotoxicity of small inflammatory mediators. VITIELLO, S., CADIC, C., GIN, H., and DUPUY, B., Horm. Metab. Res., 1992, 24, (2), 96.
  • Eradication of Fusarium infection in a leukopenic patient treated with liposomal am-photericin B. VIVIANI, M. A., COFRANCESCO, E., BOSCHETTI, C., TORTORANO, A. M., and CORTELLARO, M., Mycoses, 1991, 34, (5-6), 255–256.
  • Recent advances in the large-scale production of lipid vesicles for use in food products: microfluidization. VUILLEMARD, J. C., J. Microencapsul., 1991, 8, (4), 547–562.
  • Indomethacin microspheres: I. Formulation and in vitro evaluation. VURAL, I., Ks, H. S:, and HINCAL, A. A., Chim. Oggi, 1991, 9, (11), 47–50.
  • In vitro and in vivo antitumor activity of liposomal aclarubicin. VYADRO, M. M., and NAVASHIN, S. M., Byull. Eksp. Bio. Med., 1991, 112, (11), 523–525.
  • Liposomes for allergy immunotherapy? WALLS, A. F., Clin. Exp. Allergy, 1992, 22, (1), 1–2. Plasticizers and their effects on microencapsulation process by spray-drying in an aqueous system. WAN, L. S. C., HENG, P. W. S., and CHIA, C. G. H., J .Microencapsul., 1992,9, (1), 53–62. Preparation and characterization of wax microspheres by using oil-in-water melt dispersion technique for water-insoluble drugs. WANG, C. J., TIEN, J. H., and Kuo, P. C., Chin. Pharm. J., 1991, 43, (6), 489–500.
  • An approach to the preparation of digestive enzyme-drug for oral administration: complex lactase microcapsules. WANG, X., and SHAO, J., Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao, 1991, 13, (6), 435–438.
  • Fourier transform-Raman spectroscopy for the qualitative and quantitative characterization of sulfasalazine-containing polymeric microspheres. WATTS, P. J., TUDOR, A., CHURCH, S. J., HENDRA, P. J., TURNER, P., MELIA, C. D., and DAVIES, M. C., Pharm. Res., 1991, 8, (10), 1323–1328.
  • Surface characterization of eudragit rs-sulphasalazine microspheres using X-ray photo-electron spectroscopy (XPS). WATTS, P. J., LYNN, R. A. P., WATTS, J. F., MELIA, C. D., and DAVIES, M. C., J. Pharm. Pharmacol., 1991, 43, (Suppl.), Abstract 26P.
  • Coated alginate microspheres: factors influencing the controlled delivery of macromolecules. WHEATLEY, M. A., CHANG, M., PARK, E., and LANGER, R., J. App/. Polym, Sc., 1991, 43, (11), 2123–2135.
  • Amikacin liposomes: characterization, aerosolization, and in vitro activity against Myco-bacterium avium intracellulare in alveolar macrophages. WICHERT, B. V., GONZALEZ-ROTEII, R. J., STRAUB, L. E., WICHERT, B. M., and SCHREIER, H., Int. J. Pharm., 1992, 78, (2-3), 227–235.
  • Calcium-induced fusion of phospholipid vesicles containing free fatty acids: modulation by transmembrane pH-gradients. WILSCHUT, J., SCHOLMA, J., EASTMAN, S. J., HOPE, M. J., and CuLus, P. R., Biochemistry, 1992, 31, (10), 2629–2636.
  • New developments in biodegradable microspheres for magnetic separation techniques. WINOTO-MORBACH, S., ULRICHS, K., and MUELLER-RUCHHOLTZ, W., Immunobiology, 1991, 183, (3-4), 277–278.
  • A novel two-step procedure for immobilizing living cells in microcapsules for improving xenograft survival. WoNG, H., and CHANG, T. M. S., Biontater. Artif. Cells, Immobilization Biotechnol., 1991, 19, (4), 687–697.
  • The microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with the standard single step drop technique: histologically identified membrane imperfec-tions and the associated graft rejection. WONG, H., and CHANG, T. M. S., Biomater. Artif. Cells, Immobilization Biotechnol., 1991, 19, (4), 675–686.
  • Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat. WOODLE, M. C., STORM, G., NEWMAN, M. S., JEKOT, J. J., COLLINS, L. R., MARTIN, F. J., and SZOKA, F. C. JR., Pharm. Res., 1992, 9, (2), 260–265.
  • Relation of mean pixel intensity to concentration of sonicated albumin microspheres: effects of ultrasound system settings. WRAY, R. A., QUINONES, M. A., ZOGHBI, W. A., and CHEIRIF, J., Clin. Cardiol., 1991, 14, (11, Suppl. 5), V23–V28.
  • Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Xu, S., ARBEIT, R. D., and LEE, J. C., Infect. Immun., 1992, 60, (4), 1358–1362.
  • Incorporation of histone into liposomes increases the efficiency of liposome-mediated gene transfer. YAGI, K., Nistinumt, M., and HAYASHI, Y., J. Clin. Biochem. Nutr., 1991, 10, (1), 21–25.
  • Reconstitution of sodium/hydrogen antiporter of bovine renal brush-border membrane into proteoliposomes and detection of a 110 kDa protein cross-reactive with antibodies against a human sodium/hydrogen-antiporter partial peptide in antiport-active frac-tions after partial fractionation. YAMASHITA, T., and KAWAKITA, M., J. Biochem. (Tokyo), 1992, 111, (2), 162–167.
  • Studies on carbohydrate-binding proteins using liposome-based systems. I. Preparation of neoglycoprotein-conjugated liposomes and the feasibility of their use as drug-targeting devices. YAMAZAKI, N., XOJIMA, S., GABIUS, S., and GABIUS, H. J., Int. J Biochem., 1992, 24,(1), 99–104.
  • Anticancer gelatin microspheres with multiple functions. YAN, C. H., Li, X. W.,CHEN, X. L., WANG, D. Q., ZnoNG, D. C., TAN, T. Z., and KITANO, H., Biomaterials, 1991, 12, (7), 640–644. Polymerization of monodisperse microspheres with micron size. YAN CFIANGHONG, FANG
  • XINYUAN and LI XIONGWEI., Goafenzi Cailiao Kexue Yu Gongcheng, 1991, 7, (4), 25–29. Preparation of albendazole liposomes and its effect on Fasciola hepatica in goats. YANG, Y. S., and FuNG, K. F., Acta Vet. Scand. Suppl., 1991, 87, 406–407.
  • The entrapment of vitamin E acetate in porous spheres. YANG YOON JEONG, BAE BONG JIN, LEE Ku SiK, and CHUN IN KOO., Yakche Hakhoechi, 1991, 21, (1), 51–55.
  • Medical application of liposomes. YASUDA, T., Rinsho Byori, 1991, 91, 238–248.
  • Basic methods for preparation of liposomes. YASUDA, T., Med. Philos., 1991, 10, (9), 727–735. Palytoxin (PTX) interaction with sodium potassium ATP(ase) proteoliposomes (PLs). YODA, A., VEMURA, D., and YOGA, S., Biophys. J., 1992, 61, (2, Part 2), A263.
  • Palytoxin (PTX) interaction with NAK ATPase proteoliposomes (PLs). YODA, A., VEMURA, D., and YODA, S., FASEB (Fed. Am. Soc. Exp. Biol. J.), 1992, 6, (1), A263.
  • Anticonvulsant effect of liposome-entrapped superoxide dismutase in amygdaloid-kindled rats. YOKOYAMA, H., MORI, N., OSONOE, K., ISHIDA, S., and KUMASHIRO, H., Brain Res., 1992, 572, (1-2), 273–275.
  • Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma. YOSHIOKA, H., Biomaterials, 1991, 12, (9), 861–864. Preparation of a compound film bearing gentamicin microcapsules. Yu XiQuAN, Ltu BAOSHAN, HUANG XIAOFENG, and ZHANG JINGCAL, Zhongguo Yiyuan Yaoxue Zazhi, 1991, 11, (8), 343–345. Application of the microencapsulation technique in biomedicine. Yu YA0TING, and CL-LEN
  • CHANGZHI, Daxue Huaxue, 1990, 5, (3), 6–9.
  • Functional polymeric monolayers and liposomes. ZAITSEV, S. Yu, and Zusov, V. P., Makromol. Chem., Macromol. Symp., 1991, 46 (Eur. Conf. Organ, Org. Thin Films, 3rd, 1990), 9–17.
  • Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations. ZEISIG, R., FICHTNER, I., ARNDT, D., and JUNGMANN, S., Anticancer Drugs, 1991,2, (4), 411–417.
  • Research of liposomes entrapping pBR322. ZENG ZHIYI, CIIENG TONG, and YI JIANHUA, Wuhan Daxue Xuebao, Ziran Kexueban, 1991, (1), 124–126.
  • Encapsulation of hemoglobin in liposomes. LEH film hydration or reverse evaporation? ZHENG, S., BEISSINGER, R., McCoRmicK, D., FRESCO, R., GODWIN, J., FAREED, J., and MARTIN, F., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (2), 507.
  • An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation. ZHOU, F., ROUSE, B. I., and HUANG, L., J. Immunol. Methods, 1991, 145, (1-2), 143–152.
  • Improved encapsulation of DNA in pH-sensitive liposomes for transfection. ZHOU XIAOHUAI, KLIBANOV, A. L., and HUANG, L., J Liposome Res., 1991, 2, (1), 125–139.
  • Effects of deltamethrin on liposomes with proton NMR. ZHOU ZHE, CONG RONGJUAN, Liu Yucu, ZUO MAOI.I, and Qiu JIANGING., Weisheng Dulixue Zazhi, 1991, 5, (2), 75–76. 79.
  • Preparation and in vitro and in vivo evaluation of norethisteronejpoly(DL-lactide-co-glucolide) microspheres. ZHOU ZHIFANG, ZHOU MINGXING, and SHEN WENZHAO, Zhongguo Yaoxue Zazhi, 1991, 26, (6), 351–355.
  • In vitro degradation of polylactide and poly(lactide-co-glycolide) microspheres. ZHU JIAHUEI, SHEN ZHENGRONG, Wu LANTING, and YANG SHILIN, J. Appl. Polym. Sci., 1991, 43, (11), 2099–2106.
  • Preparation of ampicillin sodium-ethyl cellulose and sulfadimidine-gelatin microcapsules and the sustained release of the microcapsules. Znou Lula, ZHANG XIUZHEN, ZHANG JIANGANG, and CHU LIANJUN, Shandong Yike Daxue Xuebao, 1991, 29, (2), 162–164.
  • Investigation of temperature-sensitive liposome encapsulated adriamycin injected into hepatic artery for targeted behavior and cancer therapy. Zou, Y. Y., Gu, X. Q., UENO, M., and HORIKOSHI, I., Yaoxue Xuebao, 1991, 26, (9), 705–709.
  • Correction of hypoxia in acute destructive pneumonia in children by using phospholipid liposomes in a controlled germ-free environment, ZUBARENKO, A. V., and LOSEV, A. A., Pediatriia, 1991, (10), 51–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.